| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 1.18e-08 | 5 | 141 | 4 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 1.18e-08 | 5 | 141 | 4 | GO:0015501 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 1.37e-06 | 4 | 141 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 3.06e-06 | 15 | 141 | 4 | GO:0005313 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 1.06e-05 | 20 | 141 | 4 | GO:0015172 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 1.90e-05 | 23 | 141 | 4 | GO:0005283 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.34e-05 | 81 | 141 | 6 | GO:0015370 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 2.69e-05 | 25 | 141 | 4 | GO:0017056 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 4.93e-05 | 29 | 141 | 4 | GO:0005416 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.05e-04 | 35 | 141 | 4 | GO:0005343 | |
| GeneOntologyMolecularFunction | cysteine transmembrane transporter activity | 1.48e-04 | 3 | 141 | 2 | GO:0033229 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 1.97e-04 | 41 | 141 | 4 | GO:0015175 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.01e-04 | 119 | 141 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | structural molecule activity | EPB41L4B NUP62CL PPFIA2 PCLO POM121L2 NUP214 NUP58 CRYAB SHANK2 LMNA MEGF9 MUC17 VCAN CRYBG3 MUC3A MUC4 | 5.63e-04 | 891 | 141 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | phosphatase binding | 5.85e-04 | 264 | 141 | 8 | GO:0019902 | |
| GeneOntologyMolecularFunction | symporter activity | 6.93e-04 | 150 | 141 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 8.90e-04 | 27 | 141 | 3 | GO:0008139 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.23e-03 | 229 | 141 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.35e-03 | 8 | 141 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.37e-03 | 171 | 141 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.58e-03 | 308 | 141 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.60e-03 | 71 | 141 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | L-aspartate transmembrane transporter activity | 2.15e-03 | 10 | 141 | 2 | GO:0015183 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.15e-03 | 10 | 141 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 2.61e-03 | 11 | 141 | 2 | GO:0000099 | |
| GeneOntologyMolecularFunction | transcription factor binding | SETD1A SP1 PCLO SRF NR4A3 SIX3 JMJD1C BPTF CD34 KMT2A TAF4 HCFC1 MED13 | 2.65e-03 | 753 | 141 | 13 | GO:0008134 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | DOCK2 MYADM CLASP1 EPB41L4B PCLO SRF OBSL1 CLASP2 PSTPIP1 PIP5K1C ECT2 JMY CCDC88A ALMS1 MEGF9 AMOT PHACTR4 ANTXR1 PRKD1 | 3.31e-06 | 803 | 144 | 19 | GO:0030036 |
| GeneOntologyBiologicalProcess | L-aspartate import across plasma membrane | 6.56e-06 | 6 | 144 | 3 | GO:0140009 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 9.51e-06 | 195 | 144 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 1.21e-05 | 201 | 144 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | actin filament-based process | DOCK2 MYADM CLASP1 EPB41L4B PCLO SRF OBSL1 CLASP2 PSTPIP1 PIP5K1C ECT2 JMY CCDC88A ALMS1 MEGF9 AMOT PHACTR4 ANTXR1 PRKD1 | 2.00e-05 | 912 | 144 | 19 | GO:0030029 |
| GeneOntologyBiologicalProcess | eye development | RPGRIP1 SP1 HIPK1 MDM1 SRF SIX3 SLC1A1 CRYAB SALL2 ALMS1 PHACTR4 NHS CRYBG3 | 3.30e-05 | 480 | 144 | 13 | GO:0001654 |
| GeneOntologyBiologicalProcess | visual system development | RPGRIP1 SP1 HIPK1 MDM1 SRF SIX3 SLC1A1 CRYAB SALL2 ALMS1 PHACTR4 NHS CRYBG3 | 3.51e-05 | 483 | 144 | 13 | GO:0150063 |
| GeneOntologyBiologicalProcess | sensory system development | RPGRIP1 SP1 HIPK1 MDM1 SRF SIX3 SLC1A1 CRYAB SALL2 ALMS1 PHACTR4 NHS CRYBG3 | 4.16e-05 | 491 | 144 | 13 | GO:0048880 |
| GeneOntologyBiologicalProcess | camera-type eye development | RPGRIP1 SP1 HIPK1 MDM1 SRF SIX3 SLC1A1 CRYAB ALMS1 PHACTR4 NHS CRYBG3 | 4.59e-05 | 426 | 144 | 12 | GO:0043010 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 4.74e-05 | 239 | 144 | 9 | GO:0031032 | |
| GeneOntologyBiologicalProcess | L-aspartate transmembrane transport | 5.28e-05 | 11 | 144 | 3 | GO:0070778 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye morphogenesis | 7.04e-05 | 32 | 144 | 4 | GO:0048596 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 7.17e-05 | 313 | 144 | 10 | GO:0098742 | |
| GeneOntologyBiologicalProcess | nuclear transport | NUP62CL PPP1R12A POM121L2 TSC2 NUP214 NUP58 SIX3 WNK1 ECT2 LMNA PRKD1 | 7.19e-05 | 378 | 144 | 11 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | NUP62CL PPP1R12A POM121L2 TSC2 NUP214 NUP58 SIX3 WNK1 ECT2 LMNA PRKD1 | 7.19e-05 | 378 | 144 | 11 | GO:0006913 |
| GeneOntologyBiologicalProcess | cell junction maintenance | 9.12e-05 | 65 | 144 | 5 | GO:0034331 | |
| GeneOntologyBiologicalProcess | L-glutamate transmembrane transport | 1.01e-04 | 35 | 144 | 4 | GO:0015813 | |
| GeneOntologyBiologicalProcess | organelle assembly | KNTC1 RPGRIP1 CLASP1 MDM1 SRF OBSL1 CLASP2 WNK1 DNAH1 CCDC88A CELSR3 ALMS1 CELSR2 UBAP2L AP5Z1 CD34 DNAI4 PRKD1 PLK4 KIF11 | 1.28e-04 | 1138 | 144 | 20 | GO:0070925 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | KNTC1 CLASP1 MDM1 SRF OBSL1 CLASP2 WNK1 ALMS1 UBAP2L PRKD1 PLK4 KIF11 | 1.29e-04 | 475 | 144 | 12 | GO:0140694 |
| GeneOntologyBiologicalProcess | embryonic eye morphogenesis | 1.40e-04 | 38 | 144 | 4 | GO:0048048 | |
| GeneOntologyBiologicalProcess | cysteine transmembrane transport | 1.45e-04 | 3 | 144 | 2 | GO:1903712 | |
| GeneOntologyBiologicalProcess | cell junction organization | MYADM CLASP1 PSG11 HIPK1 PPFIA2 PCLO ITSN1 ADGRB3 SRF TSC2 CLASP2 PIP5K1C ECT2 SLC1A1 SHANK2 CDH7 CDH8 ADGRL3 | 1.55e-04 | 974 | 144 | 18 | GO:0034330 |
| GeneOntologyBiologicalProcess | maintenance of synapse structure | 1.71e-04 | 40 | 144 | 4 | GO:0099558 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 2.02e-04 | 171 | 144 | 7 | GO:0048593 | |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 2.17e-04 | 122 | 144 | 6 | GO:0110020 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 2.67e-04 | 179 | 144 | 7 | GO:0031023 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 2.72e-04 | 45 | 144 | 4 | GO:0031076 | |
| GeneOntologyBiologicalProcess | cysteine transport | 2.88e-04 | 4 | 144 | 2 | GO:0042883 | |
| GeneOntologyBiologicalProcess | L-glutamate import | 2.96e-04 | 46 | 144 | 4 | GO:0051938 | |
| GeneOntologyBiologicalProcess | L-glutamate import across plasma membrane | 2.98e-04 | 19 | 144 | 3 | GO:0098712 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 3.41e-04 | 246 | 144 | 8 | GO:0045216 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 3.48e-04 | 187 | 144 | 7 | GO:0007156 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 3.78e-04 | 49 | 144 | 4 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 4.09e-04 | 50 | 144 | 4 | GO:0002834 | |
| GeneOntologyBiologicalProcess | aspartate transmembrane transport | 4.66e-04 | 22 | 144 | 3 | GO:0015810 | |
| GeneOntologyBiologicalProcess | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 4.77e-04 | 5 | 144 | 2 | GO:1904261 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane assembly involved in embryonic body morphogenesis | 4.77e-04 | 5 | 144 | 2 | GO:1904259 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing, spreading of epidermal cells | 4.77e-04 | 5 | 144 | 2 | GO:1903690 | |
| GeneOntologyBiologicalProcess | basement membrane assembly involved in embryonic body morphogenesis | 4.77e-04 | 5 | 144 | 2 | GO:2001197 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 4.80e-04 | 259 | 144 | 8 | GO:0006836 | |
| GeneOntologyBiologicalProcess | regulation of nucleocytoplasmic transport | 4.90e-04 | 142 | 144 | 6 | GO:0046822 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | MYADM MUC21 SPN PSG11 SRF NR4A3 TSC2 PIP5K1C WNK1 FAT2 CELSR3 CELSR2 PTPRG CD34 MUC4 CDH7 CDH8 ADGRL3 | 5.20e-04 | 1077 | 144 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | eye morphogenesis | 5.85e-04 | 204 | 144 | 7 | GO:0048592 | |
| GeneOntologyBiologicalProcess | sensory organ development | RPGRIP1 SP1 HIPK1 MDM1 SRF NR4A3 SIX3 SLC1A1 CRYAB SALL2 ALMS1 PHACTR4 NHS CRYBG3 | 6.04e-04 | 730 | 144 | 14 | GO:0007423 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 6.23e-04 | 410 | 144 | 10 | GO:0031589 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 6.24e-04 | 98 | 144 | 5 | GO:0061045 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 6.31e-04 | 56 | 144 | 4 | GO:0002418 | |
| GeneOntologyBiologicalProcess | cell junction assembly | CLASP1 HIPK1 PCLO ADGRB3 SRF CLASP2 PIP5K1C ECT2 SHANK2 CDH7 CDH8 ADGRL3 | 6.60e-04 | 569 | 144 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | presynaptic cytoskeleton organization | 7.13e-04 | 6 | 144 | 2 | GO:0099187 | |
| GeneOntologyBiologicalProcess | D-aspartate import across plasma membrane | 7.13e-04 | 6 | 144 | 2 | GO:0070779 | |
| GeneOntologyBiologicalProcess | D-aspartate transmembrane transport | 7.13e-04 | 6 | 144 | 2 | GO:0070777 | |
| GeneOntologyBiologicalProcess | cellular component maintenance | 7.16e-04 | 101 | 144 | 5 | GO:0043954 | |
| GeneOntologyBiologicalProcess | gastrulation | 7.35e-04 | 212 | 144 | 7 | GO:0007369 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | SP1 CLASP1 EPB41L4B PSG11 SRF TSC2 CLASP2 FAT2 PTPRG AMOT PHACTR4 PRKD1 | 7.45e-04 | 577 | 144 | 12 | GO:0001667 |
| GeneOntologyBiologicalProcess | neural retina development | 7.49e-04 | 102 | 144 | 5 | GO:0003407 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | MYADM MUC21 ERBB3 CLASP1 SPN EPB41L4B PSG11 PPP1R12A SRF NR4A3 TSC2 CLASP2 WNK1 CELSR2 PTPRG MUC4 | 7.68e-04 | 927 | 144 | 16 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation of centriole replication | 7.70e-04 | 26 | 144 | 3 | GO:0046599 | |
| GeneOntologyBiologicalProcess | lens development in camera-type eye | 7.82e-04 | 103 | 144 | 5 | GO:0002088 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 8.20e-04 | 60 | 144 | 4 | GO:0015804 | |
| GeneOntologyBiologicalProcess | definitive hemopoiesis | 8.62e-04 | 27 | 144 | 3 | GO:0060216 | |
| GeneOntologyBiologicalProcess | adherens junction organization | 8.73e-04 | 61 | 144 | 4 | GO:0034332 | |
| GeneOntologyBiologicalProcess | epithelial cell migration | 9.29e-04 | 432 | 144 | 10 | GO:0010631 | |
| GeneOntologyBiologicalProcess | epithelium migration | 9.79e-04 | 435 | 144 | 10 | GO:0090132 | |
| GeneOntologyBiologicalProcess | lens induction in camera-type eye | 9.93e-04 | 7 | 144 | 2 | GO:0060235 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 1.02e-03 | 362 | 144 | 9 | GO:0034504 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix assembly | 1.07e-03 | 29 | 144 | 3 | GO:1901201 | |
| GeneOntologyBiologicalProcess | thymic T cell selection | 1.07e-03 | 29 | 144 | 3 | GO:0045061 | |
| GeneOntologyBiologicalProcess | C4-dicarboxylate transport | 1.07e-03 | 29 | 144 | 3 | GO:0015740 | |
| GeneOntologyBiologicalProcess | tissue migration | 1.09e-03 | 441 | 144 | 10 | GO:0090130 | |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 1.14e-03 | 167 | 144 | 6 | GO:0007043 | |
| GeneOntologyBiologicalProcess | Golgi organization | 1.18e-03 | 168 | 144 | 6 | GO:0007030 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 1.24e-03 | 232 | 144 | 7 | GO:0002706 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 1.30e-03 | 375 | 144 | 9 | GO:0007162 | |
| GeneOntologyBiologicalProcess | D-amino acid transport | 1.32e-03 | 8 | 144 | 2 | GO:0042940 | |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane raft | 1.32e-03 | 8 | 144 | 2 | GO:0044860 | |
| GeneOntologyCellularComponent | Golgi lumen | 7.27e-08 | 109 | 146 | 9 | GO:0005796 | |
| GeneOntologyCellularComponent | synaptic membrane | ERBB3 PPFIA2 ITSN1 ADGRB3 GRM4 PIP5K1C SLC1A2 SLC1A6 SLC1A7 CRYAB SHANK2 CELSR3 CDH8 ADGRL3 | 6.07e-05 | 583 | 146 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | MLL1 complex | 7.05e-05 | 32 | 146 | 4 | GO:0071339 | |
| GeneOntologyCellularComponent | external side of plasma membrane | SPN PSG11 MUC16 MAP3K5 MUC17 AMOT GYPA CD34 GYPE ANTXR1 ULBP2 RAET1L IL27RA | 7.37e-05 | 519 | 146 | 13 | GO:0009897 |
| GeneOntologyCellularComponent | MLL1/2 complex | 7.98e-05 | 33 | 146 | 4 | GO:0044665 | |
| GeneOntologyCellularComponent | uropod | 1.15e-04 | 14 | 146 | 3 | GO:0001931 | |
| GeneOntologyCellularComponent | cell trailing edge | 1.43e-04 | 15 | 146 | 3 | GO:0031254 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 1.81e-04 | 75 | 146 | 5 | GO:0035097 | |
| GeneOntologyCellularComponent | cell leading edge | MYADM ITSN1 CLASP2 PSTPIP1 PIP5K1C SLC1A2 JMY CCDC88A AMOT PHACTR4 ANTXR1 NHS | 2.09e-04 | 500 | 146 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | cell-cell junction | MYADM EPB41L4B PSG11 OBSL1 PIP5K1C ECT2 FAT2 AMOT NHS PRKD1 CDH7 CDH8 ADGRL3 | 2.65e-04 | 591 | 146 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | cell surface | SPN PSG11 PPFIA2 CD109 MUC16 SLC1A1 SLC1A2 MAP3K5 CRYAB MUC17 AMOT GYPA CD34 GYPE VCAN ANTXR1 ULBP2 RAET1L IL27RA | 2.74e-04 | 1111 | 146 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | kinetochore microtubule | 4.66e-04 | 22 | 146 | 3 | GO:0005828 | |
| GeneOntologyCellularComponent | cortical microtubule cytoskeleton | 4.78e-04 | 5 | 146 | 2 | GO:0030981 | |
| GeneOntologyCellularComponent | glutamatergic synapse | PPFIA2 PCLO ITSN1 ADGRB3 TSC2 CLASP2 GRM4 PIP5K1C SLC1A2 SLC1A6 SLC1A7 SHANK2 CELSR3 CDH8 ADGRL3 | 6.08e-04 | 817 | 146 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | presynaptic membrane | 7.49e-04 | 277 | 146 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | cleavage furrow | 8.75e-04 | 61 | 146 | 4 | GO:0032154 | |
| GeneOntologyCellularComponent | methyltransferase complex | 9.71e-04 | 108 | 146 | 5 | GO:0034708 | |
| GeneOntologyCellularComponent | basal cortex | 9.94e-04 | 7 | 146 | 2 | GO:0045180 | |
| GeneOntologyCellularComponent | lamellipodium | 1.19e-03 | 230 | 146 | 7 | GO:0030027 | |
| GeneOntologyCellularComponent | side of membrane | SPN PSG11 CD109 MUC16 MAP3K5 MUC17 AMOT GYPA CD34 GYPE ANTXR1 ULBP2 RAET1L MMP19 IL27RA | 1.22e-03 | 875 | 146 | 15 | GO:0098552 |
| GeneOntologyCellularComponent | neuron projection terminus | 1.28e-03 | 233 | 146 | 7 | GO:0044306 | |
| GeneOntologyCellularComponent | anchoring junction | MYADM CLASP1 EPB41L4B PSG11 PPP1R12A OBSL1 CLASP2 PIP5K1C ECT2 FAT2 AMOT NHS PRKD1 CDH7 CDH8 ADGRL3 | 1.33e-03 | 976 | 146 | 16 | GO:0070161 |
| GeneOntologyCellularComponent | centriole | 1.33e-03 | 172 | 146 | 6 | GO:0005814 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.56e-03 | 33 | 146 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | ankyrin-1 complex | 2.10e-03 | 10 | 146 | 2 | GO:0170014 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 2.13e-03 | 129 | 146 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | apical plasma membrane | ERBB3 PSG11 SLC34A3 SLC1A1 SHANK2 SLC12A3 MUC17 CD34 NHS MUC4 | 2.27e-03 | 487 | 146 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | cell division site | 2.39e-03 | 80 | 146 | 4 | GO:0032153 | |
| GeneOntologyCellularComponent | NSL complex | 2.56e-03 | 11 | 146 | 2 | GO:0044545 | |
| GeneOntologyCellularComponent | apical part of cell | ERBB3 EPB41L4B PSG11 SLC34A3 SLC1A1 SHANK2 SLC12A3 MUC17 CD34 NHS MUC4 | 3.00e-03 | 592 | 146 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | spindle microtubule | 3.11e-03 | 86 | 146 | 4 | GO:0005876 | |
| GeneOntologyCellularComponent | presynaptic active zone | 3.14e-03 | 141 | 146 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | cell projection membrane | PSG11 CLASP2 SLC34A3 PIP5K1C SLC1A2 SHANK2 MUC17 ANTXR1 MUC4 | 3.34e-03 | 431 | 146 | 9 | GO:0031253 |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 3.36e-03 | 43 | 146 | 3 | GO:0098688 | |
| GeneOntologyCellularComponent | chromatin | ANKRD31 SETD1A SP1 SP4 BAZ2B SRF KDM3B POU2F2 NR4A3 SRCAP SIX3 JMJD1C CREB5 KANSL3 BPTF RIF1 ZBTB46 TAF4 MGA HCFC1 | 3.38e-03 | 1480 | 146 | 20 | GO:0000785 |
| GeneOntologyCellularComponent | distal axon | 3.55e-03 | 435 | 146 | 9 | GO:0150034 | |
| GeneOntologyCellularComponent | axon terminus | 3.62e-03 | 210 | 146 | 6 | GO:0043679 | |
| GeneOntologyCellularComponent | cell cortex region | 3.82e-03 | 45 | 146 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | axon | PPFIA2 PCLO ITSN1 TSC2 CLASP2 GRM4 SLC1A1 SLC1A2 SLC1A7 CRYAB SHANK2 CDH8 HCFC1 ADGRL3 | 3.89e-03 | 891 | 146 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | postsynapse | ERBB3 PPFIA2 PCLO ITSN1 ADGRB3 TSC2 PIP5K1C SLC1A1 SLC1A2 SLC1A6 SLC1A7 CRYAB SHANK2 CELSR3 ADGRL3 | 5.11e-03 | 1018 | 146 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | Set1C/COMPASS complex | 5.45e-03 | 16 | 146 | 2 | GO:0048188 | |
| GeneOntologyCellularComponent | nuclear pore | 5.52e-03 | 101 | 146 | 4 | GO:0005643 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 1.04e-07 | 7 | 140 | 4 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 1.04e-07 | 7 | 140 | 4 | PS00714 | |
| Domain | SDF | 1.04e-07 | 7 | 140 | 4 | PF00375 | |
| Domain | - | 1.04e-07 | 7 | 140 | 4 | 1.10.3860.10 | |
| Domain | Na-dicarboxylate_symporter | 1.04e-07 | 7 | 140 | 4 | IPR001991 | |
| Domain | Na-dicarboxylate_symporter_CS | 1.04e-07 | 7 | 140 | 4 | IPR018107 | |
| Domain | GAIN_dom_N | 9.58e-07 | 11 | 140 | 4 | IPR032471 | |
| Domain | GAIN | 9.58e-07 | 11 | 140 | 4 | PF16489 | |
| Domain | GPS | 5.15e-06 | 34 | 140 | 5 | SM00303 | |
| Domain | GPS | 5.97e-06 | 35 | 140 | 5 | PF01825 | |
| Domain | GPS | 6.89e-06 | 36 | 140 | 5 | PS50221 | |
| Domain | GPS | 7.92e-06 | 37 | 140 | 5 | IPR000203 | |
| Domain | GPCR_2_extracellular_dom | 1.17e-05 | 40 | 140 | 5 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.17e-05 | 40 | 140 | 5 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.17e-05 | 40 | 140 | 5 | PS50227 | |
| Domain | SEA | 2.40e-05 | 23 | 140 | 4 | PS50024 | |
| Domain | SEA_dom | 2.40e-05 | 23 | 140 | 4 | IPR000082 | |
| Domain | HormR | 3.38e-05 | 25 | 140 | 4 | SM00008 | |
| Domain | 7tm_2 | 3.56e-05 | 50 | 140 | 5 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 3.56e-05 | 50 | 140 | 5 | PS00650 | |
| Domain | HRM | 5.38e-05 | 28 | 140 | 4 | PF02793 | |
| Domain | Mucin_dom | 5.58e-05 | 2 | 140 | 2 | IPR028199 | |
| Domain | Epiglycanin_C | 5.58e-05 | 2 | 140 | 2 | PF14654 | |
| Domain | GPCR_2_secretin-like | 8.64e-05 | 60 | 140 | 5 | IPR000832 | |
| Domain | GPCR_2-like | 8.64e-05 | 60 | 140 | 5 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 9.35e-05 | 61 | 140 | 5 | PS50261 | |
| Domain | GPCR_2_secretin-like_CS | 1.18e-04 | 34 | 140 | 4 | IPR017983 | |
| Domain | EGF_1 | 1.33e-04 | 255 | 140 | 9 | PS00022 | |
| Domain | SEA | 1.41e-04 | 14 | 140 | 3 | SM00200 | |
| Domain | EGF-like_CS | 1.58e-04 | 261 | 140 | 9 | IPR013032 | |
| Domain | EGF_2 | 1.77e-04 | 265 | 140 | 9 | PS01186 | |
| Domain | VWF_type-D | 2.15e-04 | 16 | 140 | 3 | IPR001846 | |
| Domain | VWFD | 2.15e-04 | 16 | 140 | 3 | PS51233 | |
| Domain | VWD | 2.15e-04 | 16 | 140 | 3 | SM00216 | |
| Domain | VWD | 2.15e-04 | 16 | 140 | 3 | PF00094 | |
| Domain | Mib_Herc2 | 3.31e-04 | 4 | 140 | 2 | IPR010606 | |
| Domain | MIB_HERC2 | 3.31e-04 | 4 | 140 | 2 | PS51416 | |
| Domain | MIB_HERC2 | 3.31e-04 | 4 | 140 | 2 | PF06701 | |
| Domain | CLASP_N | 3.31e-04 | 4 | 140 | 2 | PF12348 | |
| Domain | DDT | 3.31e-04 | 4 | 140 | 2 | PF02791 | |
| Domain | CLASP_N_dom | 3.31e-04 | 4 | 140 | 2 | IPR024395 | |
| Domain | Glycophorin | 3.31e-04 | 4 | 140 | 2 | IPR001195 | |
| Domain | EGF | 4.01e-04 | 235 | 140 | 8 | SM00181 | |
| Domain | DDT | 5.50e-04 | 5 | 140 | 2 | SM00571 | |
| Domain | DDT_dom | 5.50e-04 | 5 | 140 | 2 | IPR018501 | |
| Domain | WHIM2_dom | 5.50e-04 | 5 | 140 | 2 | IPR028941 | |
| Domain | WSD | 5.50e-04 | 5 | 140 | 2 | PF15613 | |
| Domain | SEA | 5.72e-04 | 22 | 140 | 3 | PF01390 | |
| Domain | EGF-like_dom | 5.87e-04 | 249 | 140 | 8 | IPR000742 | |
| Domain | DDT | 8.20e-04 | 6 | 140 | 2 | PS50827 | |
| Domain | ARM-like | 9.93e-04 | 270 | 140 | 8 | IPR011989 | |
| Domain | HECT | 1.06e-03 | 27 | 140 | 3 | PF00632 | |
| Domain | HECTc | 1.06e-03 | 27 | 140 | 3 | SM00119 | |
| Domain | HECT_dom | 1.06e-03 | 27 | 140 | 3 | IPR000569 | |
| Domain | HECT | 1.06e-03 | 27 | 140 | 3 | PS50237 | |
| Domain | Cadherin_CS | 1.38e-03 | 109 | 140 | 5 | IPR020894 | |
| Domain | EGF_LAM_2 | 1.44e-03 | 30 | 140 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.44e-03 | 30 | 140 | 3 | PS01248 | |
| Domain | CADHERIN_1 | 1.62e-03 | 113 | 140 | 5 | PS00232 | |
| Domain | Cadherin | 1.62e-03 | 113 | 140 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 1.68e-03 | 114 | 140 | 5 | PS50268 | |
| Domain | - | 1.68e-03 | 114 | 140 | 5 | 2.60.40.60 | |
| Domain | CA | 1.75e-03 | 115 | 140 | 5 | SM00112 | |
| Domain | Cadherin-like | 1.82e-03 | 116 | 140 | 5 | IPR015919 | |
| Domain | Cadherin | 1.96e-03 | 118 | 140 | 5 | IPR002126 | |
| Domain | EGF_3 | 1.99e-03 | 235 | 140 | 7 | PS50026 | |
| Domain | EGF_Lam | 2.26e-03 | 35 | 140 | 3 | SM00180 | |
| Domain | Laminin_EGF | 2.26e-03 | 35 | 140 | 3 | PF00053 | |
| Domain | Sp1_fam | 2.41e-03 | 10 | 140 | 2 | IPR030450 | |
| Domain | EGF | 2.61e-03 | 126 | 140 | 5 | PF00008 | |
| Domain | LAM_G_DOMAIN | 2.87e-03 | 38 | 140 | 3 | PS50025 | |
| Domain | Laminin_EGF | 2.87e-03 | 38 | 140 | 3 | IPR002049 | |
| Domain | Rap_GAP_dom | 2.94e-03 | 11 | 140 | 2 | IPR000331 | |
| Domain | RAPGAP | 2.94e-03 | 11 | 140 | 2 | PS50085 | |
| Domain | Laminin_G_2 | 3.33e-03 | 40 | 140 | 3 | PF02210 | |
| Domain | C8 | 3.51e-03 | 12 | 140 | 2 | PF08742 | |
| Domain | TIL | 3.51e-03 | 12 | 140 | 2 | PF01826 | |
| Domain | BROMODOMAIN_2 | 3.57e-03 | 41 | 140 | 3 | PS50014 | |
| Domain | Bromodomain | 3.82e-03 | 42 | 140 | 3 | IPR001487 | |
| Domain | BROMO | 3.82e-03 | 42 | 140 | 3 | SM00297 | |
| Domain | - | 3.82e-03 | 42 | 140 | 3 | 1.20.920.10 | |
| Domain | Unchr_dom_Cys-rich | 4.12e-03 | 13 | 140 | 2 | IPR014853 | |
| Domain | C8 | 4.12e-03 | 13 | 140 | 2 | SM00832 | |
| Domain | LamG | 4.36e-03 | 44 | 140 | 3 | SM00282 | |
| Domain | TIL_dom | 4.79e-03 | 14 | 140 | 2 | IPR002919 | |
| Domain | Znf_FYVE_PHD | 5.03e-03 | 147 | 140 | 5 | IPR011011 | |
| Domain | - | 5.49e-03 | 15 | 140 | 2 | 3.30.70.960 | |
| Domain | - | 5.69e-03 | 95 | 140 | 4 | 2.60.120.200 | |
| Domain | GRAM | 6.25e-03 | 16 | 140 | 2 | SM00568 | |
| Domain | Post-SET_dom | 6.25e-03 | 16 | 140 | 2 | IPR003616 | |
| Domain | PostSET | 6.25e-03 | 16 | 140 | 2 | SM00508 | |
| Domain | POST_SET | 6.25e-03 | 16 | 140 | 2 | PS50868 | |
| Domain | - | 6.61e-03 | 222 | 140 | 6 | 1.25.10.10 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.67e-11 | 16 | 111 | 7 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.82e-11 | 17 | 111 | 7 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.42e-10 | 23 | 111 | 7 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 9.01e-10 | 26 | 111 | 7 | M27483 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.03e-08 | 21 | 111 | 6 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 5.34e-07 | 62 | 111 | 7 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.01e-06 | 68 | 111 | 7 | M27303 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.04e-06 | 24 | 111 | 5 | MM14834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.04e-06 | 24 | 111 | 5 | M630 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 7.37e-06 | 60 | 111 | 6 | MM15636 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.69e-05 | 143 | 111 | 8 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.69e-05 | 111 | 111 | 7 | M27416 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 4.87e-05 | 51 | 111 | 5 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 4.87e-05 | 51 | 111 | 5 | MM14499 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.18e-04 | 140 | 111 | 7 | M27484 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.08e-04 | 108 | 111 | 6 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.18e-04 | 109 | 111 | 6 | MM15074 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.18e-04 | 109 | 111 | 6 | MM15164 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.19e-04 | 38 | 111 | 4 | MM17073 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 2.67e-04 | 40 | 111 | 4 | MM15060 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 3.24e-04 | 42 | 111 | 4 | M48018 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 5.43e-04 | 48 | 111 | 4 | MM15069 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 8.02e-04 | 250 | 111 | 8 | M27554 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 1.10e-03 | 99 | 111 | 5 | M27474 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 1.11e-03 | 58 | 111 | 4 | M11980 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 6.08e-13 | 18 | 146 | 7 | 18834073 | |
| Pubmed | SETD1A PPP1R12A FNBP4 KDM3B HUWE1 SRCAP ANKHD1 UBN2 JMJD1C BPTF ALMS1 SUGP2 UBAP2L AMOT PHACTR4 KMT2A TAF4 MGA HCFC1 | 2.16e-12 | 549 | 146 | 19 | 38280479 | |
| Pubmed | SP1 HIPK1 ITSN1 NUP214 MUC12 NUP58 WNK1 SLC1A2 MAP3K5 ZNF106 RIF1 TSC22D1 CCDC88A KIAA1549L HERC2 MGA | 2.72e-10 | 486 | 146 | 16 | 20936779 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CLASP1 PPP1R12A RALGAPB KDM3B TSC2 CLASP2 WNK1 ECT2 ZNF106 CCDC88A ALMS1 AMOT PHACTR4 KMT2A NHS CRYBG3 HECTD1 PLK4 PRRC1 KIF11 | 6.53e-10 | 861 | 146 | 20 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EPB41L4B PPFIA2 PPP1R12A RALGAPB FNBP4 SRF CLASP2 HUWE1 UBN2 SLC1A1 JMJD1C DNAH1 KANSL3 KLHL29 BPTF ZBTB46 TSC22D1 SHANK2 PTPRG SUGP2 UBAP2L RBM5 ANTXR1 PRKD1 TAF4 HECTD1 | 6.56e-10 | 1489 | 146 | 26 | 28611215 |
| Pubmed | CLASP1 NHSL2 PPP1R12A ITSN1 ADGRB3 TSC2 CLASP2 HUWE1 GRM4 UBN2 SLC1A2 MAP3K5 CCDC88A SHANK2 CELSR2 UBAP2L PRKD1 TAF4 HERC2 MGA KIF11 | 7.29e-10 | 963 | 146 | 21 | 28671696 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | HIPK1 PPP1R12A OBSL1 MTMR1 POU2F2 HUWE1 ANKHD1 ECT2 JMJD1C CREB5 CRYAB KANSL3 BPTF RIF1 SALL2 SUGP2 AP5Z1 MGA HCFC1 | 3.87e-09 | 857 | 146 | 19 | 25609649 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SP1 CLASP1 ITSN1 RALGAPB FNBP4 KDM3B NUP214 HUWE1 KANSL3 BPTF ZNF106 RIF1 LMNA SUGP2 UBAP2L PHACTR4 KMT2A MED13 | 4.92e-09 | 774 | 146 | 18 | 15302935 |
| Pubmed | KNTC1 CLASP1 ITSN1 KDM3B CLASP2 NUP214 HUWE1 WNK1 JMJD1C ZNF106 CCDC88A ALMS1 RBM5 MGA HECTD1 HCFC1 PRRC1 | 1.41e-08 | 733 | 146 | 17 | 34672954 | |
| Pubmed | 1.46e-08 | 104 | 146 | 8 | 9205841 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KNTC1 CLASP1 HIPK1 ITSN1 OBSL1 NUP58 HUWE1 SRCAP UBN2 WNK1 KANSL3 CCDC88A SALL2 ALMS1 CRYBG3 | 3.06e-08 | 588 | 146 | 15 | 38580884 |
| Pubmed | 3.69e-08 | 9 | 146 | 4 | 9693030 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 4.02e-08 | 167 | 146 | 9 | 20362541 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A KDM3B TSC2 CLASP2 NUP214 HUWE1 SRCAP ANKHD1 PIP5K1C WNK1 MAP3K5 KANSL3 SHANK2 CELSR3 CELSR2 SUGP2 HERC2 HECTD1 HCFC1 MED13 | 4.27e-08 | 1105 | 146 | 20 | 35748872 |
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 17578910 | ||
| Pubmed | CLASP1 HIPK1 RALGAPB OBSL1 NUP214 PIP5K1C KLHL29 GRAMD1B SUGP2 MEGF9 UBAP2L ADGRL3 | 1.69e-07 | 407 | 146 | 12 | 12693553 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 2.63e-07 | 33 | 146 | 5 | 25713288 | |
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 16600856 | ||
| Pubmed | The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms. | 2.89e-07 | 4 | 146 | 3 | 37224017 | |
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 9379843 | ||
| Pubmed | MYADM CLASP1 EPB41L4B PPFIA2 PPP1R12A PCLO ITSN1 MTMR1 CLASP2 SLC1A2 JMY CRYAB GRAMD1B SHANK2 LMNA SUGP2 UBAP2L AMOT VCAN KMT2A HADH | 6.19e-07 | 1431 | 146 | 21 | 37142655 | |
| Pubmed | 7.20e-07 | 5 | 146 | 3 | 9129177 | ||
| Pubmed | EPB41L4B KDM3B MUC16 CLASP2 HUWE1 DMXL1 RIF1 CCDC88A SUGP2 AMOT PHACTR4 RBM5 GCC1 MGA PRRC1 | 1.07e-06 | 777 | 146 | 15 | 35844135 | |
| Pubmed | CLASP2 WNK1 ECT2 JMJD1C MAP3K5 CRYAB ALMS1 LMNA AMOT RBM5 MGA MED13 | 1.39e-06 | 497 | 146 | 12 | 23414517 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CLASP1 PPP1R12A FNBP4 CLASP2 NUP214 ZNF106 KMT2A TAF4 MMP19 MUC4 CDH7 HCFC1 | 1.39e-06 | 497 | 146 | 12 | 36774506 |
| Pubmed | 1.44e-06 | 6 | 146 | 3 | 19110483 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.54e-06 | 332 | 146 | 10 | 32786267 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.67e-06 | 134 | 146 | 7 | 25452129 | |
| Pubmed | NUP214 HUWE1 ANKHD1 JMJD1C CCDC88A SALL2 ALMS1 AMOT CRYBG3 MGA KIF11 | 1.70e-06 | 418 | 146 | 11 | 34709266 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | VEZF1 BAZ2B KDM3B SRCAP UBN2 JMJD1C BPTF RIF1 KMT2A TAF4 HERC2 MGA HCFC1 | 1.91e-06 | 608 | 146 | 13 | 36089195 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SETD1A SP1 SP4 ITSN1 NUP214 PIP5K1C WNK1 LMNA MGA PRRC1 ADGRL3 | 2.23e-06 | 430 | 146 | 11 | 35044719 |
| Pubmed | SETD1A SP1 VEZF1 NUP214 SRCAP ANKHD1 UBN2 JMJD1C KANSL3 BPTF RIF1 SALL2 ALMS1 SUGP2 UBAP2L KMT2A TAF4 HERC2 MGA HCFC1 | 2.42e-06 | 1429 | 146 | 20 | 35140242 | |
| Pubmed | SETD1A FNBP4 ADGRB3 KDM3B NUP58 ANKHD1 KANSL3 CCDC88A CELSR3 AMOT AP5Z1 MED13 | 2.64e-06 | 529 | 146 | 12 | 14621295 | |
| Pubmed | KNTC1 RPGRIP1 VEZF1 NHSL2 PPFIA2 PPP1R12A PCLO ITSN1 FAM114A2 SRCAP CREBRF BPTF SHANK2 LMNA RBM5 KMT2A ANTXR1 TAF4 MED13 KIF11 | 2.77e-06 | 1442 | 146 | 20 | 35575683 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | KDM3B UBN2 JMJD1C KANSL3 ZNF106 SALL2 LMNA UBAP2L TAF4 MGA HCFC1 | 3.03e-06 | 444 | 146 | 11 | 34795231 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ERBB3 CLASP1 EPB41L4B CLASP2 ECT2 JMJD1C CELSR3 LMNA HADH KIF11 | 3.25e-06 | 361 | 146 | 10 | 26167880 |
| Pubmed | ERBB3 EPB41L4B RALGAPB OBSL1 KDM3B ANKHD1 ECT2 JMJD1C CCDC88A KMT2A ANTXR1 CRYBG3 HCFC1 | 3.95e-06 | 650 | 146 | 13 | 38777146 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | NUP62CL PSG11 KDM3B MUC16 PSTPIP1 CRYAB KLHL29 GRAMD1B SHANK2 SUGP2 HERC2 MUC3A | 4.07e-06 | 552 | 146 | 12 | 10737800 |
| Pubmed | DOCK2 KNTC1 SP4 VEZF1 CLASP1 BAZ2B KDM3B UBN2 JMJD1C KANSL3 BPTF SUGP2 RBM5 KMT2A TAF4 HCFC1 KIF11 | 4.19e-06 | 1103 | 146 | 17 | 34189442 | |
| Pubmed | 5.31e-06 | 225 | 146 | 8 | 12168954 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 6.44e-06 | 231 | 146 | 8 | 16452087 | |
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 6.52e-06 | 29 | 146 | 4 | 15203201 | |
| Pubmed | DOCK2 KNTC1 BAZ2B UBN2 WNK1 JMJD1C TSC22D1 FAT2 ALMS1 MGA HECTD1 | 8.16e-06 | 493 | 146 | 11 | 15368895 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 8.39e-06 | 171 | 146 | 7 | 20201926 | |
| Pubmed | 8.51e-06 | 10 | 146 | 3 | 24244196 | ||
| Pubmed | 8.59e-06 | 31 | 146 | 4 | 15960975 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP1 VEZF1 BAZ2B FNBP4 NUP214 SRCAP UBN2 JMJD1C KANSL3 BPTF ZNF106 RIF1 LMNA RBM5 KMT2A TAF4 MGA HCFC1 | 8.76e-06 | 1294 | 146 | 18 | 30804502 |
| Pubmed | 1.17e-05 | 11 | 146 | 3 | 25315821 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | VEZF1 BAZ2B FNBP4 NUP214 UBN2 JMJD1C BPTF RIF1 LMNA SUGP2 UBAP2L KMT2A TAF4 MGA HCFC1 | 1.26e-05 | 954 | 146 | 15 | 36373674 |
| Pubmed | The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer. | 1.27e-05 | 71 | 146 | 5 | 29346117 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.40e-05 | 123 | 146 | 6 | 26912792 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.50e-05 | 341 | 146 | 9 | 32971831 | |
| Pubmed | 1.55e-05 | 12 | 146 | 3 | 27563068 | ||
| Pubmed | 1.65e-05 | 263 | 146 | 8 | 34702444 | ||
| Pubmed | 1.72e-05 | 347 | 146 | 9 | 17114649 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 16914514 | ||
| Pubmed | Mucins: a biologically relevant glycan barrier in mucosal protection. | 1.75e-05 | 2 | 146 | 2 | 24821013 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 26035354 | ||
| Pubmed | Molecular cloning of two glutamate transporter subtypes from mouse brain. | 1.75e-05 | 2 | 146 | 2 | 7766664 | |
| Pubmed | The orphan nuclear receptor NOR-1 interacts with the homeobox containing protein Six3. | 1.75e-05 | 2 | 146 | 2 | 11173923 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 25538041 | ||
| Pubmed | Mammalian CLASPs are required for mitotic spindle organization and kinetochore alignment. | 1.75e-05 | 2 | 146 | 2 | 16866869 | |
| Pubmed | Interaction between intrinsically disordered regions in transcription factors Sp1 and TAF4. | 1.75e-05 | 2 | 146 | 2 | 27515574 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 10790539 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 22765916 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 19701196 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 27009953 | ||
| Pubmed | Intersectin-1 interacts with the golgin GCC88 to couple the actin network and Golgi architecture. | 1.75e-05 | 2 | 146 | 2 | 30540523 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 1421409 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 17360917 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 23544943 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 15187084 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 14690056 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 23941741 | ||
| Pubmed | Gene mutations in sporadic lymphangioleiomyomatosis and genotype-phenotype correlation analysis. | 1.75e-05 | 2 | 146 | 2 | 36117164 | |
| Pubmed | Glutamate transporters EAAT4 and EAAT5 are expressed in vestibular hair cells and calyx endings. | 1.75e-05 | 2 | 146 | 2 | 23049999 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 25175639 | ||
| Pubmed | Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics. | 1.75e-05 | 2 | 146 | 2 | 12837247 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 28857320 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 15523651 | ||
| Pubmed | Functional properties of the retinal glutamate transporters GLT-1c and EAAT5. | 1.75e-05 | 2 | 146 | 2 | 24307171 | |
| Pubmed | Membrane-bound mucin modular domains: from structure to function. | 1.75e-05 | 2 | 146 | 2 | 23178705 | |
| Pubmed | Chromatin remodeling complex NURF regulates thymocyte maturation. | 1.75e-05 | 2 | 146 | 2 | 21289071 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 24211587 | ||
| Pubmed | Mast, a conserved microtubule-associated protein required for bipolar mitotic spindle organization. | 1.75e-05 | 2 | 146 | 2 | 10899121 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 24127197 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 19438726 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 9742090 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 12543801 | ||
| Pubmed | The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures. | 1.75e-05 | 2 | 146 | 2 | 12614333 | |
| Pubmed | 1.77e-05 | 76 | 146 | 5 | 27542412 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETD1A FNBP4 NUP214 HUWE1 SRCAP LMNA UBAP2L AMOT HERC2 HECTD1 | 1.82e-05 | 440 | 146 | 10 | 34244565 |
| Pubmed | An approach based on a genome-wide association study reveals candidate loci for narcolepsy. | 1.84e-05 | 193 | 146 | 7 | 20677014 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.88e-05 | 351 | 146 | 9 | 38297188 | |
| Pubmed | 1.89e-05 | 268 | 146 | 8 | 33640491 | ||
| Pubmed | 1.92e-05 | 130 | 146 | 6 | 12421765 | ||
| Pubmed | 2.10e-05 | 197 | 146 | 7 | 36604605 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 2.15e-05 | 357 | 146 | 9 | 37059091 | |
| Pubmed | NUP214 HUWE1 ANKHD1 BPTF RIF1 LMNA SUGP2 UBAP2L KMT2A HERC2 HECTD1 HCFC1 | 2.17e-05 | 653 | 146 | 12 | 22586326 | |
| Pubmed | 2.55e-05 | 14 | 146 | 3 | 16452088 | ||
| Interaction | BAG2 interactions | SETD1A SP1 PPP1R12A TEDC2 FNBP4 OBSL1 KDM3B HUWE1 ANKHD1 UBN2 WNK1 ECT2 BPTF SALL2 AMOT AP5Z1 PHACTR4 KIF11 | 2.60e-07 | 622 | 138 | 18 | int:BAG2 |
| Interaction | NUP43 interactions | SETD1A BAZ2B PPP1R12A MUC19 NUP214 SRCAP UBN2 JMJD1C KANSL3 BPTF RIF1 CCDC88A SALL2 LMNA KMT2A TAF4 MGA HCFC1 | 2.79e-07 | 625 | 138 | 18 | int:NUP43 |
| Interaction | YWHAH interactions | CLASP1 NHSL2 PPP1R12A RALGAPB KDM3B TSC2 CLASP2 HUWE1 WNK1 ECT2 MAP3K5 ZNF106 CCDC88A ALMS1 AMOT PHACTR4 KMT2A NHS PRKD1 CRYBG3 HECTD1 PLK4 PRRC1 KIF11 | 4.38e-07 | 1102 | 138 | 24 | int:YWHAH |
| Interaction | TERF2IP interactions | SETD1A ARPP21 KDM3B SRCAP ECT2 KANSL3 BPTF RIF1 SALL2 SUGP2 RBM5 KMT2A TAF4 MGA HECTD1 HCFC1 | 1.24e-06 | 552 | 138 | 16 | int:TERF2IP |
| Interaction | CALM1 interactions | SP1 ERBB3 ARPP21 OBSL1 KDM3B TSC2 HUWE1 GRM4 WNK1 ECT2 GFM2 DMXL1 GRAMD1B CCDC88A PHACTR4 PRKD1 HERC2 | 1.38e-06 | 626 | 138 | 17 | int:CALM1 |
| Interaction | ELF1 interactions | 2.51e-06 | 126 | 138 | 8 | int:ELF1 | |
| Interaction | YWHAZ interactions | ERBB3 CLASP1 PPFIA2 PPP1R12A TEDC2 RALGAPB OBSL1 MTMR1 TSC2 CLASP2 HUWE1 WNK1 ECT2 MAP3K5 GRAMD1B CCDC88A LMNA PHACTR4 KMT2A NHS PRKD1 HERC2 HECTD1 PLK4 KIF11 | 3.07e-06 | 1319 | 138 | 25 | int:YWHAZ |
| Interaction | NFYC interactions | 3.68e-06 | 177 | 138 | 9 | int:NFYC | |
| Interaction | PHF21A interactions | NUP62CL NUP214 NUP58 HUWE1 ANKHD1 JMJD1C CCDC88A SALL2 ALMS1 AMOT CRYBG3 MGA | 4.36e-06 | 343 | 138 | 12 | int:PHF21A |
| Interaction | H2AZ1 interactions | OBSL1 SRCAP ECT2 JMJD1C DNAH1 BPTF RIF1 LMNA ULBP2 TAF4 PLK4 HCFC1 | 9.64e-06 | 371 | 138 | 12 | int:H2AZ1 |
| Interaction | RUVBL1 interactions | SETD1A PPP1R12A ITSN1 OBSL1 HUWE1 PSTPIP1 SRCAP ANKHD1 ECT2 LMNA KMT2A TAF4 MGA HECTD1 HCFC1 | 9.69e-06 | 575 | 138 | 15 | int:RUVBL1 |
| Interaction | POU5F1 interactions | SP1 ERBB3 MUC16 TSC2 HUWE1 UBN2 JMJD1C BPTF RIF1 SALL2 UBAP2L MGA HCFC1 PRRC1 KIF11 | 1.16e-05 | 584 | 138 | 15 | int:POU5F1 |
| Interaction | NUP93 interactions | 1.68e-05 | 269 | 138 | 10 | int:NUP93 | |
| Interaction | SFN interactions | SETD1A CLASP1 PPP1R12A TSC2 CLASP2 WNK1 MAP3K5 CCDC88A ALMS1 LMNA AMOT KMT2A NHS CRYBG3 HECTD1 PLK4 | 2.15e-05 | 692 | 138 | 16 | int:SFN |
| Interaction | BUB3 interactions | 3.22e-05 | 232 | 138 | 9 | int:BUB3 | |
| Interaction | YWHAG interactions | CLASP1 NHSL2 PPP1R12A RALGAPB KDM3B TSC2 CLASP2 HUWE1 WNK1 MAP3K5 ZNF106 CCDC88A ALMS1 LMNA AMOT PHACTR4 KMT2A NHS PRKD1 HECTD1 PLK4 PRRC1 | 3.96e-05 | 1248 | 138 | 22 | int:YWHAG |
| Interaction | OTUD7A interactions | 4.79e-05 | 58 | 138 | 5 | int:OTUD7A | |
| Interaction | CTNNB1 interactions | SP1 SPN PPP1R12A OBSL1 NUP214 HUWE1 ECT2 CRYAB TSC22D1 CCDC88A ZFYVE9 LMNA AMOT KMT2A NHS HERC2 HECTD1 CDH7 CDH8 | 5.92e-05 | 1009 | 138 | 19 | int:CTNNB1 |
| Interaction | CREBBP interactions | SETD1A SP1 HIPK1 SRF KDM3B NR4A3 CLASP2 HUWE1 SRCAP MAP3K5 ZNF106 RBM5 KMT2A MGA | 6.44e-05 | 599 | 138 | 14 | int:CREBBP |
| Interaction | NAA11 interactions | 6.62e-05 | 62 | 138 | 5 | int:NAA11 | |
| Interaction | ESRRB interactions | 8.24e-05 | 262 | 138 | 9 | int:ESRRB | |
| Interaction | FHL2 interactions | 9.08e-05 | 396 | 138 | 11 | int:FHL2 | |
| Interaction | ELF2 interactions | 1.01e-04 | 156 | 138 | 7 | int:ELF2 | |
| Interaction | NUP155 interactions | OBSL1 TSC2 NUP214 NUP58 HUWE1 ECT2 GRAMD1B ZFYVE9 ALMS1 LMNA CRYBG3 HECTD1 | 1.11e-04 | 477 | 138 | 12 | int:NUP155 |
| Interaction | NUP62CL interactions | 1.17e-04 | 37 | 138 | 4 | int:NUP62CL | |
| Interaction | HNF4A interactions | 1.19e-04 | 275 | 138 | 9 | int:HNF4A | |
| Interaction | FHL3 interactions | 1.22e-04 | 276 | 138 | 9 | int:FHL3 | |
| Interaction | CIT interactions | CLASP1 NUP62CL HIPK1 PPP1R12A PCLO CD109 OBSL1 CLASP2 ECT2 MAP3K5 BPTF RIF1 ALMS1 LMNA CELSR2 SUGP2 UBAP2L RBM5 KMT2A ANTXR1 DNAI4 HCFC1 KIF11 | 1.29e-04 | 1450 | 138 | 23 | int:CIT |
| Interaction | ELF4 interactions | 1.41e-04 | 115 | 138 | 6 | int:ELF4 | |
| Interaction | HMGA1 interactions | 1.49e-04 | 419 | 138 | 11 | int:HMGA1 | |
| Interaction | WWTR1 interactions | PPP1R12A SRCAP ANKHD1 JMJD1C BPTF ALMS1 SUGP2 AMOT PHACTR4 KMT2A HCFC1 | 1.59e-04 | 422 | 138 | 11 | int:WWTR1 |
| Interaction | RBBP4 interactions | SETD1A SP1 TEDC2 ITSN1 OBSL1 HUWE1 UBN2 ECT2 BPTF LMNA KMT2A HECTD1 HCFC1 | 1.59e-04 | 573 | 138 | 13 | int:RBBP4 |
| Interaction | PHF20L1 interactions | 1.64e-04 | 75 | 138 | 5 | int:PHF20L1 | |
| Interaction | NFIX interactions | 1.73e-04 | 227 | 138 | 8 | int:NFIX | |
| Interaction | DISC1 interactions | ITSN1 ANKHD1 CRYAB CCDC88A ALMS1 LMNA UBAP2L AMOT GCC1 PRKD1 HERC2 | 1.83e-04 | 429 | 138 | 11 | int:DISC1 |
| Interaction | ETS1 interactions | 1.86e-04 | 121 | 138 | 6 | int:ETS1 | |
| Interaction | HCFC1 interactions | 1.91e-04 | 293 | 138 | 9 | int:HCFC1 | |
| Interaction | ERC2 interactions | 1.93e-04 | 42 | 138 | 4 | int:ERC2 | |
| Interaction | PFN1 interactions | KNTC1 PCLO ITSN1 RALGAPB OBSL1 ANKHD1 WNK1 JMY ALMS1 CRYBG3 HECTD1 KIF11 | 2.02e-04 | 509 | 138 | 12 | int:PFN1 |
| Interaction | E2F3 interactions | 2.10e-04 | 79 | 138 | 5 | int:E2F3 | |
| Interaction | MCRS1 interactions | 2.19e-04 | 235 | 138 | 8 | int:MCRS1 | |
| Interaction | PML interactions | SP1 HIPK1 CD109 SRF KDM3B UBN2 ECT2 SLC1A2 JMJD1C KANSL3 ZNF106 ZFYVE9 LMNA UBAP2L KMT2A TAF4 HCFC1 | 2.21e-04 | 933 | 138 | 17 | int:PML |
| Interaction | ATOH1 interactions | 2.23e-04 | 80 | 138 | 5 | int:ATOH1 | |
| Interaction | H2AP interactions | 2.50e-04 | 82 | 138 | 5 | int:H2AP | |
| Interaction | MED4 interactions | ITSN1 HUWE1 WNK1 ALMS1 UBAP2L AMOT GCC1 HERC2 HECTD1 MED13 KIF11 | 2.76e-04 | 450 | 138 | 11 | int:MED4 |
| Interaction | MGAM2 interactions | 2.77e-04 | 4 | 138 | 2 | int:MGAM2 | |
| Interaction | CXXC1 interactions | 2.99e-04 | 132 | 138 | 6 | int:CXXC1 | |
| Interaction | FOS interactions | 3.05e-04 | 312 | 138 | 9 | int:FOS | |
| Interaction | PPP1CA interactions | PPP1R21 PPP1R12A OBSL1 TSC2 HUWE1 ECT2 RIF1 ZFYVE9 PHACTR4 PRKD1 HADH HERC2 HCFC1 PRRC1 | 3.06e-04 | 696 | 138 | 14 | int:PPP1CA |
| Interaction | KANSL3 interactions | 3.13e-04 | 86 | 138 | 5 | int:KANSL3 | |
| Interaction | PELP1 interactions | 3.29e-04 | 189 | 138 | 7 | int:PELP1 | |
| Interaction | FASN interactions | SP1 VEZF1 OBSL1 TSC2 CLASP2 MUC12 SLC34A3 HUWE1 WNK1 ECT2 LMNA RBM5 KMT2A NHS TAF4 MGA MED13 KIF11 | 3.44e-04 | 1062 | 138 | 18 | int:FASN |
| Interaction | FBXO22 interactions | CLASP1 PPP1R12A FNBP4 CLASP2 NUP214 ZNF106 KMT2A TAF4 MMP19 MUC4 CDH7 HCFC1 | 3.46e-04 | 540 | 138 | 12 | int:FBXO22 |
| Interaction | LURAP1 interactions | 3.65e-04 | 137 | 138 | 6 | int:LURAP1 | |
| GeneFamily | CD molecules|Mucins | 1.02e-15 | 21 | 101 | 9 | 648 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 9.24e-05 | 3 | 101 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 9.24e-05 | 3 | 101 | 2 | 1189 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.35e-04 | 181 | 101 | 6 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.06e-03 | 36 | 101 | 3 | 823 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 1.08e-03 | 9 | 101 | 2 | 755 | |
| GeneFamily | CD molecules|Type II classical cadherins | 2.32e-03 | 13 | 101 | 2 | 1186 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | KNTC1 SP1 TSC2 WNK1 BPTF ZNF106 RIF1 CELSR2 PHACTR4 HCFC1 MED13 | 5.00e-09 | 180 | 144 | 11 | M8239 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SP4 ARPP21 PPFIA2 PCLO MUC19 FAM114A2 POU2F2 TSC2 SIX3 GRM4 UBN2 SLC1A2 CREBRF FAT2 CCDC88A SHANK2 KIAA1549L CELSR3 SUGP2 MEGF9 VCAN CDH8 ADGRL3 | 3.89e-08 | 1106 | 144 | 23 | M39071 |
| Coexpression | NABA_ECM_AFFILIATED | 4.41e-07 | 170 | 144 | 9 | M5880 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | ERBB3 CLASP1 BAZ2B PPP1R12A MAP3K5 BPTF RIF1 FAT2 MEGF9 PLK4 KIF11 | 8.93e-07 | 300 | 144 | 11 | M8702 |
| Coexpression | PILON_KLF1_TARGETS_UP | KNTC1 ITSN1 RALGAPB OBSL1 CLASP2 HUWE1 SUGP2 AMOT GYPA GYPE RBM5 KMT2A HECTD1 MED13 | 1.82e-06 | 541 | 144 | 14 | MM1061 |
| Coexpression | PILON_KLF1_TARGETS_UP | KNTC1 ITSN1 RALGAPB OBSL1 CLASP2 HUWE1 SUGP2 AMOT GYPA RBM5 KMT2A HECTD1 MED13 | 4.40e-06 | 503 | 144 | 13 | M2226 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | ARPP21 PPFIA2 PCLO POU2F2 UBN2 SLC1A6 BPTF SHANK2 CELSR2 PHACTR4 KMT2A | 1.07e-05 | 389 | 144 | 11 | M39102 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | RALGAPB MTMR1 NUP58 ANKHD1 ECT2 CREB5 GFM2 RIF1 CCDC88A CELSR3 VCAN ULBP2 HECTD1 PLK4 KIF11 | 1.08e-05 | 721 | 144 | 15 | M10237 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | CLASP1 HIPK1 RALGAPB FNBP4 NR4A3 NUP58 JMY DNAH1 GRAMD1B RIF1 SUGP2 HECTD1 | 1.28e-05 | 474 | 144 | 12 | M40991 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.49e-05 | 199 | 144 | 8 | M5893 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | ARPP21 PPFIA2 PCLO ADGRB3 MUC19 POU2F2 GRM4 UBN2 SLC1A2 ZBTB46 CCDC88A SHANK2 KIAA1549L CDH8 | 3.48e-05 | 703 | 144 | 14 | M39070 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | PPP1R21 SP1 ERBB3 EPB41L4B KDM3B UBN2 SLC1A1 MAP3K5 ZBTB46 TSC22D1 SHANK2 ALMS1 PTPRG RBM5 HECTD1 | 3.99e-05 | 807 | 144 | 15 | M16651 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | VEZF1 CLASP1 BAZ2B PPP1R12A ITSN1 KDM3B CLASP2 CREB5 BPTF RIF1 ZFYVE9 TAF4 CRYBG3 MED13 KIF11 | 7.74e-05 | 856 | 144 | 15 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | ITSN1 MUC19 OBSL1 NR4A3 CREB5 MAP3K5 CRYAB FAT2 SALL2 ANTXR1 DNAI4 PLTP | 8.17e-05 | 574 | 144 | 12 | M39056 |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 1.02e-04 | 194 | 144 | 7 | M7313 | |
| Coexpression | GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP | 1.05e-04 | 195 | 144 | 7 | M8140 | |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 1.05e-04 | 195 | 144 | 7 | M7310 | |
| Coexpression | GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN | 1.05e-04 | 195 | 144 | 7 | M5396 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 1.10e-04 | 338 | 144 | 9 | M17094 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP | 1.12e-04 | 197 | 144 | 7 | M3136 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 1.16e-04 | 198 | 144 | 7 | M7948 | |
| Coexpression | GSE17721_CTRL_VS_LPS_12H_BMDC_UP | 1.20e-04 | 199 | 144 | 7 | M3701 | |
| Coexpression | ODONNELL_TFRC_TARGETS_DN | 1.22e-04 | 139 | 144 | 6 | M6451 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN | 1.23e-04 | 200 | 144 | 7 | M9361 | |
| Coexpression | GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_UP | 1.23e-04 | 200 | 144 | 7 | M9384 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 1.23e-04 | 200 | 144 | 7 | M5851 | |
| Coexpression | GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_UP | 1.23e-04 | 200 | 144 | 7 | M6269 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN | 1.23e-04 | 200 | 144 | 7 | M5169 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 1.23e-04 | 200 | 144 | 7 | M9215 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_4 | 1.41e-04 | 48 | 144 | 4 | M3141 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.54e-04 | 145 | 144 | 6 | M1810 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | OR5P2 SP1 PCLO OBSL1 WNK1 MAP3K5 RIF1 CCDC88A ALMS1 VCAN RBM5 | 1.63e-04 | 526 | 144 | 11 | M2520 |
| Coexpression | GAUTAM_EYE_CORNEA_CYTOTOXIC_T_CELLS | 1.72e-04 | 148 | 144 | 6 | M43625 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_4 | 1.79e-04 | 51 | 144 | 4 | MM516 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | MYADM EPB41L4B PCLO ITSN1 SLC1A1 CREBRF IGSF10 TSC22D1 CELSR3 CD34 KMT2A DNAI4 MUC4 | 1.80e-04 | 721 | 144 | 13 | M1999 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DOCK2 VEZF1 SPN HIPK1 PPP1R12A RALGAPB FNBP4 POU2F2 HUWE1 PSTPIP1 WNK1 JMJD1C JMY CREBRF BPTF RIF1 CCDC88A KMT2A MED13 IL27RA | 1.97e-04 | 1492 | 144 | 20 | M40023 |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP | 2.07e-04 | 368 | 144 | 9 | M16431 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.28e-04 | 221 | 144 | 7 | M39222 | |
| Coexpression | BIDUS_METASTASIS_UP | 2.28e-04 | 221 | 144 | 7 | M15866 | |
| Coexpression | DESCARTES_MAIN_FETAL_GRANULE_NEURONS | 2.32e-04 | 22 | 144 | 3 | M40087 | |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 2.41e-04 | 223 | 144 | 7 | M17621 | |
| Coexpression | NABA_ECM_AFFILIATED | 2.45e-04 | 158 | 144 | 6 | MM17063 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CLASP1 BAZ2B PPP1R12A ITSN1 CLASP2 BPTF ZFYVE9 TAF4 MED13 KIF11 | 2.64e-04 | 466 | 144 | 10 | M13522 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | MUC21 CD109 MUC19 MUC16 MUC5B MUC12 MEGF9 MUC17 MUC22 MMP19 MUC3A MUC4 HCFC1 | 2.66e-04 | 751 | 144 | 13 | M5885 |
| Coexpression | FISCHER_DREAM_TARGETS | KNTC1 SP1 MYADM SP4 TEDC2 MDM1 FNBP4 NUP58 ECT2 RIF1 ALMS1 HADH PLK4 HCFC1 KIF11 | 2.97e-04 | 969 | 144 | 15 | M149 |
| Coexpression | DELYS_THYROID_CANCER_DN | 3.14e-04 | 233 | 144 | 7 | M13273 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.09e-06 | 124 | 144 | 8 | gudmap_developingGonad_e16.5_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500 | 2.87e-06 | 91 | 144 | 7 | gudmap_developingGonad_e14.5_ epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.45e-06 | 105 | 144 | 7 | gudmap_developingGonad_e18.5_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 9.47e-06 | 72 | 144 | 6 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | SETD1A SP1 CLASP1 NHSL2 FNBP4 OBSL1 SRCAP DMXL1 RIF1 RBM5 MGA PLTP | 2.57e-05 | 413 | 144 | 12 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SETD1A SP1 CLASP1 NHSL2 FNBP4 ADGRB3 OBSL1 SRCAP JMJD1C SLC16A12 DMXL1 CRYAB RIF1 LMNA RBM5 MGA PLTP | 3.04e-05 | 799 | 144 | 17 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SETD1A SP1 SP4 CLASP1 NHSL2 BAZ2B FNBP4 ADGRB3 OBSL1 SRCAP JMJD1C SLC16A12 DMXL1 RIF1 RBM5 MGA PLTP | 3.14e-05 | 801 | 144 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 3.21e-05 | 89 | 144 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_500 | 3.64e-05 | 91 | 144 | 6 | gudmap_developingGonad_e16.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.01e-05 | 136 | 144 | 7 | gudmap_developingGonad_P2_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.30e-05 | 146 | 144 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.76e-05 | 330 | 144 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SETD1A SP1 CLASP1 NHSL2 FNBP4 ADGRB3 OBSL1 SRCAP JMJD1C SLC16A12 DMXL1 RIF1 MEGF9 RBM5 MGA PLTP | 9.41e-05 | 790 | 144 | 16 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | SETD1A SP1 SP4 NHSL2 FNBP4 OBSL1 SRCAP SLC16A12 DMXL1 CRYAB RIF1 LMNA CD34 RBM5 MGA PLTP | 1.04e-04 | 797 | 144 | 16 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | SETD1A SP1 CLASP1 NHSL2 FNBP4 OBSL1 SRCAP DMXL1 RBM5 MGA PLTP | 1.05e-04 | 406 | 144 | 11 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | ARPP21 NHSL2 PPFIA2 MDM1 SLC1A2 CREB5 MAP3K5 IGSF10 CCDC88A KIAA1549L ALMS1 GYPA ANTXR1 NHS MUC4 CDH7 CDH8 ADGRL3 | 1.14e-04 | 978 | 144 | 18 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SETD1A SP1 CLASP1 NHSL2 OBSL1 HUWE1 SRCAP ECT2 JMJD1C DMXL1 RIF1 PTPRG UBAP2L RBM5 PRKD1 MGA | 1.15e-04 | 804 | 144 | 16 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SETD1A SP1 SP4 CLASP1 NHSL2 FNBP4 OBSL1 SRCAP ANKHD1 ECT2 DMXL1 RIF1 UBAP2L RBM5 MGA PLTP | 1.19e-04 | 806 | 144 | 16 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 1.90e-04 | 78 | 144 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SP4 PPP1R12A PCLO MDM1 SRCAP WNK1 ECT2 SLC1A2 BPTF ZFYVE9 CELSR2 HECTD1 CDH8 | 2.12e-04 | 595 | 144 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | C5orf22 EPB41L4B CD109 ADGRB3 CLASP2 NUP214 KLHL29 RIF1 PTPRG MEGF9 GYPA VCAN DNAI4 MED13 ADGRL3 | 2.36e-04 | 769 | 144 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | C5orf22 PPP1R12A RALGAPB MTMR1 NUP214 NUP58 HUWE1 SRCAP JMY MED13 | 2.47e-04 | 375 | 144 | 10 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.48e-04 | 182 | 144 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | SETD1A SP1 SP4 HUWE1 SRCAP ANKHD1 ECT2 JMJD1C DMXL1 CREBRF RIF1 ALMS1 UBAP2L RBM5 MGA | 2.60e-04 | 776 | 144 | 15 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.65e-04 | 184 | 144 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.69e-04 | 379 | 144 | 10 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | MYADM ARPP21 EPB41L4B PPFIA2 ADGRB3 DNAAF9 SLC1A1 SLC1A2 CREB5 MAP3K5 CRYAB IGSF10 KIAA1549L ANTXR1 CDH7 CDH8 ADGRL3 | 3.05e-04 | 967 | 144 | 17 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | MYADM ARPP21 EPB41L4B NUP62CL PPFIA2 ADGRB3 DNAAF9 SLC1A1 SLC1A2 CREB5 MAP3K5 IGSF10 KIAA1549L ANTXR1 CDH7 CDH8 ADGRL3 | 3.05e-04 | 967 | 144 | 17 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 3.37e-04 | 390 | 144 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | SP4 ERBB3 ARPP21 PCLO MDM1 SIX3 SLC1A2 CREB5 MAP3K5 IGSF10 KIAA1549L CELSR2 ANTXR1 NHS MUC4 CDH8 ADGRL3 | 3.72e-04 | 984 | 144 | 17 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | PCLO MDM1 ADGRB3 NR4A3 SIX3 ANKHD1 ECT2 SLC1A2 RIF1 CCDC88A KIAA1549L ALMS1 CELSR2 DNAI4 HECTD1 CDH7 CDH8 | 3.95e-04 | 989 | 144 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-IIint.Bl, CD115+ B220- CD43- Ly6C- MHCIIint, Blood, avg-5 | MYADM SPN MDM1 POU2F2 MAP3K5 CCDC88A ZFYVE9 MEGF9 CRYBG3 PLTP | 4.11e-04 | 400 | 144 | 10 | GSM605886_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.18e-04 | 261 | 144 | 8 | gudmap_developingGonad_e12.5_epididymis_k1_1000 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.Bl, CD115+ B220- CD43- Ly6C- MHCII-, Blood, avg-3 | MYADM SPN MDM1 POU2F2 MAP3K5 CCDC88A ZFYVE9 MEGF9 CRYBG3 PLTP | 4.28e-04 | 402 | 144 | 10 | GSM605883_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | SETD1A SP1 CLASP1 NHSL2 ITSN1 FNBP4 ADGRB3 SRCAP ECT2 JMJD1C DMXL1 RIF1 UBAP2L RBM5 MGA | 4.36e-04 | 815 | 144 | 15 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 4.36e-04 | 403 | 144 | 10 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_500 | 4.59e-04 | 53 | 144 | 4 | gudmap_developingGonad_P2_epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | ARPP21 NUP62CL PPFIA2 SLC1A2 CREB5 MAP3K5 IGSF10 KIAA1549L ANTXR1 CDH8 ADGRL3 | 5.16e-04 | 489 | 144 | 11 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.36e-04 | 271 | 144 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | ARPP21 VEZF1 EPB41L4B HUWE1 RIF1 CCDC88A MEGF9 VCAN ANTXR1 MED13 ADGRL3 | 5.43e-04 | 492 | 144 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.63e-04 | 150 | 144 | 6 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.70e-04 | 209 | 144 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | PCLO MDM1 ADGRB3 SIX3 SLC1A2 RIF1 KIAA1549L ALMS1 CELSR2 CDH7 CDH8 | 6.00e-04 | 498 | 144 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.92e-04 | 156 | 144 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_500 | 7.37e-04 | 60 | 144 | 4 | gudmap_developingGonad_e12.5_ovary_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | SP4 PPFIA2 PCLO ADGRB3 MTMR1 CREB5 CREBRF KIAA1549L CELSR2 MEGF9 DNAI4 CDH7 CDH8 | 7.81e-04 | 683 | 144 | 13 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | MDM1 CLASP2 NUP214 HUWE1 SRCAP SIX3 JMY RIF1 ZBTB46 SALL2 MEGF9 VCAN TAF4 MED13 | 8.57e-04 | 779 | 144 | 14 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | ARPP21 PPFIA2 ADGRB3 DNAAF9 SIX3 SLC1A2 ZXDA CREB5 MAP3K5 IGSF10 KIAA1549L GYPA ANTXR1 CDH7 CDH8 ADGRL3 | 8.84e-04 | 967 | 144 | 16 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | BAZ2B PPFIA2 PCLO MUC19 MUC16 JMJD1C CREB5 CCDC88A MEGF9 VCAN | 6.22e-10 | 186 | 146 | 10 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.52e-07 | 193 | 146 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.30e-07 | 200 | 146 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.14e-06 | 179 | 146 | 7 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.22e-06 | 180 | 146 | 7 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.22e-06 | 180 | 146 | 7 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 2.47e-06 | 183 | 146 | 7 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 2.56e-06 | 184 | 146 | 7 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.85e-06 | 187 | 146 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.96e-06 | 188 | 146 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.96e-06 | 188 | 146 | 7 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.06e-06 | 189 | 146 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.28e-06 | 191 | 146 | 7 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.89e-06 | 196 | 146 | 7 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.02e-06 | 197 | 146 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.02e-06 | 197 | 146 | 7 | e239caae24f40564a24ad909754f5436f767ccdb | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.16e-06 | 198 | 146 | 7 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.16e-06 | 198 | 146 | 7 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.30e-06 | 199 | 146 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-05 | 160 | 146 | 6 | 6215ac6123a295f3c2f033786602a57b2e2e1177 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.53e-05 | 161 | 146 | 6 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 1.95e-05 | 168 | 146 | 6 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-05 | 169 | 146 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.09e-05 | 170 | 146 | 6 | 5bb577e2c4bd275fbe4ee23ff8c007b2fcb90e56 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.30e-05 | 173 | 146 | 6 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-05 | 173 | 146 | 6 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.38e-05 | 174 | 146 | 6 | 66df78280f657978c4a568010ae7d7943869af90 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.54e-05 | 176 | 146 | 6 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.62e-05 | 177 | 146 | 6 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 178 | 146 | 6 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.79e-05 | 179 | 146 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 2.88e-05 | 180 | 146 | 6 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 2.97e-05 | 181 | 146 | 6 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 182 | 146 | 6 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.25e-05 | 184 | 146 | 6 | d1ea2b60fb1ca1a0b809d131310c43903a9e84ce | |
| ToppCell | (8)_CD34_progenitor|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.46e-05 | 186 | 146 | 6 | 943c604a7cd873faf510096d094100512ba2d6bc | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-05 | 186 | 146 | 6 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | (8)_CD34_progenitor|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.46e-05 | 186 | 146 | 6 | e69a986b8618effd61875fda528a2e44aab11868 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.56e-05 | 187 | 146 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 3.78e-05 | 189 | 146 | 6 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | COVID-19_Severe-HSPC|World / disease group, cell group and cell class | 3.78e-05 | 189 | 146 | 6 | 555c0b13f1508b9e3712b36d77144e73e828bc76 | |
| ToppCell | COVID-19_Severe-HSPC|COVID-19_Severe / disease group, cell group and cell class | 3.78e-05 | 189 | 146 | 6 | 96015439971e2e5b8d6294ca5a6b873c7774e925 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 3.78e-05 | 189 | 146 | 6 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-05 | 189 | 146 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.89e-05 | 190 | 146 | 6 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 190 | 146 | 6 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.89e-05 | 190 | 146 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 3.89e-05 | 190 | 146 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.01e-05 | 191 | 146 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.01e-05 | 191 | 146 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-05 | 192 | 146 | 6 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.13e-05 | 192 | 146 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.13e-05 | 192 | 146 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.13e-05 | 192 | 146 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-05 | 192 | 146 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.13e-05 | 192 | 146 | 6 | 61677831b096b36f6325e9cb047483dd72aa71c2 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.25e-05 | 193 | 146 | 6 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-05 | 193 | 146 | 6 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | Control-Classical_Monocyte|Control / Disease condition and Cell class | 4.37e-05 | 194 | 146 | 6 | 9e33e1b54b4114f9e6981819834bb796ed7192b5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.37e-05 | 194 | 146 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.37e-05 | 194 | 146 | 6 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.50e-05 | 195 | 146 | 6 | ae98215b7b7f22f1aca690920ce6092dc4a3c7db | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.50e-05 | 195 | 146 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.50e-05 | 195 | 146 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.50e-05 | 195 | 146 | 6 | 6fcab7aa4db958ccad0300adea9aaae52ace5bff | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 4.50e-05 | 195 | 146 | 6 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 195 | 146 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 195 | 146 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Healthy-Classical_Monocyte|Healthy / disease group, cell group and cell class | 4.63e-05 | 196 | 146 | 6 | 27d24aa2fd4521cf7e410688ed3b11b2d9700dd2 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 4.63e-05 | 196 | 146 | 6 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.63e-05 | 196 | 146 | 6 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.63e-05 | 196 | 146 | 6 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.76e-05 | 197 | 146 | 6 | 751f19b00f92e1334f653b870d3f7c0c149ff41a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-05 | 197 | 146 | 6 | aec598543d9a6bd20670bc9855d6531a5ba995fa | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 4.76e-05 | 197 | 146 | 6 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.76e-05 | 197 | 146 | 6 | 6e96a6c2576f52b72aeab1e41f47a0af05ff327a | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.76e-05 | 197 | 146 | 6 | 2701864e49878c5f323f5133e2c4b0a5a7fff7f5 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.76e-05 | 197 | 146 | 6 | a80be1081f3ed0aceea69a33be21bca6bc354472 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.76e-05 | 197 | 146 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.76e-05 | 197 | 146 | 6 | 7870c0651caefb0ed13d9f9dab43b5f24d6a9efc | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.76e-05 | 197 | 146 | 6 | 58d809ccb8cc4b1e76acf0b8f996cd0e2637290c | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.90e-05 | 198 | 146 | 6 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.90e-05 | 198 | 146 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | (0)_Myeloid|World / immune cells in Peripheral Blood (logTPM normalization) | 4.90e-05 | 198 | 146 | 6 | aca971ee9d6801bea52288d86b44defa9e306969 | |
| ToppCell | PBMC-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.90e-05 | 198 | 146 | 6 | a8338da2477ccf8e3d924de8dbe1056b98111532 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.90e-05 | 198 | 146 | 6 | 70e62d815b2a0aa5327ff94d6f4d503176e007b9 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.90e-05 | 198 | 146 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.90e-05 | 198 | 146 | 6 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | remission-Classical_Monocyte|World / disease stage, cell group and cell class | 4.90e-05 | 198 | 146 | 6 | 056b8745e753b1a500cf58d09a2ebf38707e1357 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.90e-05 | 198 | 146 | 6 | 51c220507bb05aa6338fec494b8ecf4902437708 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 4.90e-05 | 198 | 146 | 6 | b88c4c0ed1abf0a28dbe05b04b9bee1073855ba8 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.90e-05 | 198 | 146 | 6 | 6d547122b8c4ddbdd0d3dae3bce4a125740d5457 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 4.90e-05 | 198 | 146 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | PBMC-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.90e-05 | 198 | 146 | 6 | 603846129560d5d6e6df27d6168f67f592e5e6e2 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.03e-05 | 199 | 146 | 6 | a272c54baf8de59c0f259e6498d144a0de8d8924 | |
| ToppCell | Control-Control-Others-HSPC|Control / Disease, condition lineage and cell class | 5.03e-05 | 199 | 146 | 6 | b71169be0d916b2ed139a3122d78bb154c71edb4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 199 | 146 | 6 | 9b02acae6325b0ac9642438a4431285ff396e5fe | |
| ToppCell | distal-Hematologic-Classical_Monocyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.03e-05 | 199 | 146 | 6 | cd691f1c2493516d7553cc9a005f6e3b442bdbd5 | |
| ToppCell | COVID-19-COVID-19_Mild-Others-HSPC|COVID-19_Mild / Disease, condition lineage and cell class | 5.03e-05 | 199 | 146 | 6 | 0230103c37ae3aff58240739b89f2c36b1e39a69 | |
| ToppCell | COVID-19_Severe-Myeloid|COVID-19_Severe / Disease group, lineage and cell class | 5.03e-05 | 199 | 146 | 6 | babbf3220cc811a1794032e06c6cec4dfc7bff2f | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | ARPP21 PSG11 PCLO ADGRB3 NUP214 HUWE1 SLC1A1 CCDC88A MUC4 CDH8 | 5.66e-07 | 200 | 143 | 10 | 4820_UP |
| Drug | anthglutin | 1.02e-06 | 13 | 143 | 4 | CID000125748 | |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; HL60; HT_HG-U133A | 4.45e-06 | 197 | 143 | 9 | 3065_DN | |
| Drug | ST021200; Up 200; 10uM; MCF7; HT_HG-U133A | 4.63e-06 | 198 | 143 | 9 | 7488_UP | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | SETD1A NUP62CL NUP214 PIP5K1C GRPR MAP3K5 ZFYVE9 AP5Z1 HCFC1 | 4.83e-06 | 199 | 143 | 9 | 6240_UP |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; MCF7; HT_HG-U133A | 4.83e-06 | 199 | 143 | 9 | 2754_DN | |
| Drug | Ge 3 | 8.22e-06 | 21 | 143 | 4 | CID000444690 | |
| Drug | beta-hydroxyaspartic acid | 1.13e-05 | 47 | 143 | 5 | CID000005425 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.19e-05 | 184 | 143 | 8 | 2321_DN | |
| Drug | Magnetite Nanoparticles | BAZ2B CD109 SRF POU2F2 ECT2 JMJD1C SLC16A12 MAP3K5 GRAMD1B RIF1 TSC22D1 CCDC88A SLC12A3 UBAP2L RBM5 MGA MMP19 HECTD1 PLK4 PRRC1 MED13 KIF11 | 2.31e-05 | 1310 | 143 | 22 | ctd:D058185 |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.56e-05 | 188 | 143 | 8 | 3257_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.87e-05 | 191 | 143 | 8 | 6644_DN | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | 3.09e-05 | 193 | 143 | 8 | 5839_DN | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; PC3; HT_HG-U133A | 3.09e-05 | 193 | 143 | 8 | 4226_DN | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 143 | 8 | 4828_UP | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 143 | 8 | 3854_UP | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HG-U133A | 3.20e-05 | 194 | 143 | 8 | 1924_DN | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 143 | 8 | 4126_DN | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 143 | 8 | 3855_UP | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 3.32e-05 | 195 | 143 | 8 | 1649_DN | |
| Drug | Chlorpyrifos | SP1 PPP1R12A PCLO FNBP4 SRF HUWE1 GRM4 SLC1A1 SLC1A2 SLC1A6 SLC1A7 CRYAB ZNF106 AMOT RBM5 KMT2A PRKD1 KIF11 | 3.37e-05 | 960 | 143 | 18 | ctd:D004390 |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 3536_DN | |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 4484_UP | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 1629_DN | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 3144_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 3847_UP | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 6559_UP | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 3783_DN | |
| Drug | Cortisone [53-06-5]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.57e-05 | 197 | 143 | 8 | 7458_UP | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; HL60; HG-U133A | 3.57e-05 | 197 | 143 | 8 | 1726_UP | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.70e-05 | 198 | 143 | 8 | 4750_DN | |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.70e-05 | 198 | 143 | 8 | 7010_DN | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A | 3.70e-05 | 198 | 143 | 8 | 6668_DN | |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; PC3; HT_HG-U133A | 3.70e-05 | 198 | 143 | 8 | 7370_DN | |
| Drug | cyclosporine A; Down 200; 1uM; MCF7; HG-U133A | 3.70e-05 | 198 | 143 | 8 | 602_DN | |
| Drug | PF-00539758-00 [351321-34-1]; Down 200; 10uM; PC3; HT_HG-U133A | 3.70e-05 | 198 | 143 | 8 | 6421_DN | |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.84e-05 | 199 | 143 | 8 | 4352_DN | |
| Drug | minocycline; Up 200; 10.5uM; MCF7; HT_HG-U133A_EA | 3.84e-05 | 199 | 143 | 8 | 1135_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; MCF7; HT_HG-U133A | 3.84e-05 | 199 | 143 | 8 | 4691_UP | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 3.84e-05 | 199 | 143 | 8 | 3128_DN | |
| Drug | Ysdspstst | 3.86e-05 | 11 | 143 | 3 | CID003083137 | |
| Drug | k02 | 3.92e-05 | 2 | 143 | 2 | CID016122638 | |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; HL60; HG-U133A | 3.98e-05 | 200 | 143 | 8 | 1376_DN | |
| Drug | Chlorpropamide [94-20-2]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 3.98e-05 | 200 | 143 | 8 | 5391_UP | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; HL60; HT_HG-U133A | 3.98e-05 | 200 | 143 | 8 | 2534_UP | |
| Drug | ethyldichloroarsine | 6.71e-05 | 35 | 143 | 4 | CID000011711 | |
| Drug | L-Glutamic Acid | 6.91e-05 | 68 | 143 | 5 | DB00142 | |
| Drug | cellobiitol | 8.39e-05 | 37 | 143 | 4 | CID000003871 | |
| Drug | benzyloxyaspartate | 8.39e-05 | 37 | 143 | 4 | CID004133412 | |
| Drug | AC1L9FMM | 9.71e-05 | 73 | 143 | 5 | CID000444055 | |
| Drug | Androgen Antagonists | 1.10e-04 | 75 | 143 | 5 | ctd:D000726 | |
| Drug | B-E4 | 1.17e-04 | 3 | 143 | 2 | CID000449115 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.18e-04 | 174 | 143 | 7 | 5693_DN | |
| Drug | Succimer | BAZ2B CD109 POU2F2 ECT2 JMJD1C SLC16A12 MAP3K5 GRAMD1B RIF1 TSC22D1 CCDC88A SLC12A3 UBAP2L RBM5 MGA HECTD1 PLK4 PRRC1 MED13 KIF11 | 1.27e-04 | 1264 | 143 | 20 | ctd:D004113 |
| Drug | Securinine [5610-40-2]; Up 200; 18.4uM; PC3; HT_HG-U133A | 1.51e-04 | 181 | 143 | 7 | 4493_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.56e-04 | 182 | 143 | 7 | 3887_DN | |
| Drug | guanidine hydrochloride | 1.67e-04 | 129 | 143 | 6 | CID000005742 | |
| Drug | enzacamene | 1.67e-04 | 129 | 143 | 6 | ctd:C038939 | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 1.72e-04 | 185 | 143 | 7 | 1114_DN | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.72e-04 | 185 | 143 | 7 | 6243_UP | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.84e-04 | 187 | 143 | 7 | 4989_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.84e-04 | 187 | 143 | 7 | 4323_DN | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A | 1.96e-04 | 189 | 143 | 7 | 3084_UP | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 1.96e-04 | 189 | 143 | 7 | 5936_DN | |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 1.96e-04 | 189 | 143 | 7 | 7074_DN | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 1.96e-04 | 189 | 143 | 7 | 4450_UP | |
| Drug | AC1L1BXF | 2.00e-04 | 85 | 143 | 5 | CID000001650 | |
| Drug | D90A | 2.00e-04 | 85 | 143 | 5 | CID000023715 | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 2.03e-04 | 190 | 143 | 7 | 2299_DN | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; HL60; HT_HG-U133A | 2.10e-04 | 191 | 143 | 7 | 1328_UP | |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.10e-04 | 191 | 143 | 7 | 3861_UP | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.16e-04 | 192 | 143 | 7 | 6044_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 2.16e-04 | 192 | 143 | 7 | 2523_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.23e-04 | 193 | 143 | 7 | 3845_UP | |
| Drug | Bromperidol [10457-90-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 193 | 143 | 7 | 2872_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.23e-04 | 193 | 143 | 7 | 4712_UP | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 2.30e-04 | 194 | 143 | 7 | 1670_DN | |
| Drug | YVN | 2.33e-04 | 4 | 143 | 2 | CID009547990 | |
| Drug | bmtp | 2.33e-04 | 4 | 143 | 2 | CID000130819 | |
| Drug | K0 1 | 2.33e-04 | 4 | 143 | 2 | CID001190625 | |
| Drug | Li Bo | 2.33e-04 | 4 | 143 | 2 | CID006327674 | |
| Drug | Sulmazole [73384-60-8]; Down 200; 14uM; HL60; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 2153_DN | |
| Drug | Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 5024_UP | |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 2517_UP | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 4235_DN | |
| Drug | Flecainide acetate [54143-56-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 3843_UP | |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 6561_UP | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 5021_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 3860_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 2897_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 1665_DN | |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Up 200; 11.4uM; HL60; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 3038_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 2071_DN | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 4557_UP | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; HL60; HT_HG-U133A | 2.45e-04 | 196 | 143 | 7 | 1840_UP | |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.45e-04 | 196 | 143 | 7 | 4482_UP | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.45e-04 | 196 | 143 | 7 | 7378_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 2.45e-04 | 196 | 143 | 7 | 1326_UP | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; HL60; HT_HG-U133A | 2.45e-04 | 196 | 143 | 7 | 2158_DN | |
| Drug | Isosorbide dinitrate [87-33-2]; Down 200; 17uM; HL60; HT_HG-U133A | 2.45e-04 | 196 | 143 | 7 | 2183_DN | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 2.16e-06 | 6 | 142 | 3 | DOID:0050994 (implicated_via_orthology) | |
| Disease | level of UL16-binding protein 6 in blood serum | 2.30e-05 | 2 | 142 | 2 | OBA_2043185 | |
| Disease | lymphangioleiomyomatosis (is_implicated_in) | 6.88e-05 | 3 | 142 | 2 | DOID:3319 (is_implicated_in) | |
| Disease | Holoprosencephaly | 7.06e-05 | 17 | 142 | 3 | C0079541 | |
| Disease | red blood cell density measurement | PPP1R21 SP1 SP4 ITSN1 WNK1 JMJD1C ZNF106 ZBTB46 GYPA GYPE ANTXR1 MUC4 PLTP KIF11 | 9.35e-05 | 880 | 142 | 14 | EFO_0007978 |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 1.55e-04 | 56 | 142 | 4 | EFO_0022250 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.67e-04 | 57 | 142 | 4 | EFO_0022284 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.82e-04 | 243 | 142 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 1.91e-04 | 59 | 142 | 4 | EFO_0022289 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.17e-04 | 61 | 142 | 4 | DOID:3587 (is_marker_for) | |
| Disease | diabetic neuropathy | 2.28e-04 | 5 | 142 | 2 | EFO_1000783 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.61e-04 | 64 | 142 | 4 | DOID:4947 (is_marker_for) | |
| Disease | mean corpuscular hemoglobin concentration | PPP1R21 KNTC1 SP1 CLASP1 ITSN1 TSC2 DMXL1 KLHL29 RIF1 UBAP2L GYPA GYPE ANTXR1 PLK4 MED13 | 2.94e-04 | 1105 | 142 | 15 | EFO_0004528 |
| Disease | sexual dimorphism measurement | ANKRD31 POM121L2 TSC2 GRM4 JMJD1C CREB5 KLHL29 BPTF ZBTB46 SLC12A3 PTPRG GYPA GYPE MGA PLTP | 2.97e-04 | 1106 | 142 | 15 | EFO_0021796 |
| Disease | free cholesterol in large VLDL measurement | 3.30e-04 | 68 | 142 | 4 | EFO_0022265 | |
| Disease | gas trapping measurement | 3.64e-04 | 29 | 142 | 3 | EFO_0007628 | |
| Disease | fish oil supplement exposure measurement, high density lipoprotein cholesterol measurement | 4.75e-04 | 7 | 142 | 2 | EFO_0004612, EFO_0600007 | |
| Disease | Bipolar Disorder | 5.25e-04 | 477 | 142 | 9 | C0005586 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 5.40e-04 | 291 | 142 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | lung carcinoma | 5.65e-04 | 482 | 142 | 9 | EFO_0001071 | |
| Disease | C-reactive protein measurement, high density lipoprotein cholesterol measurement | 5.85e-04 | 34 | 142 | 3 | EFO_0004458, EFO_0004612 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 6.77e-04 | 144 | 142 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | Nerve Degeneration | 7.04e-04 | 83 | 142 | 4 | C0027746 | |
| Disease | adiponectin measurement | 7.20e-04 | 146 | 142 | 5 | EFO_0004502 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 8.78e-04 | 39 | 142 | 3 | EFO_0022332 | |
| Disease | ciliopathy (implicated_via_orthology) | 9.46e-04 | 40 | 142 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | free cholesterol in medium LDL measurement | 9.46e-04 | 40 | 142 | 3 | EFO_0022268 | |
| Disease | Asthma, Occupational | 1.01e-03 | 10 | 142 | 2 | C0264423 | |
| Disease | otitis media (is_marker_for) | 1.01e-03 | 10 | 142 | 2 | DOID:10754 (is_marker_for) | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 1.17e-03 | 43 | 142 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | chronic bronchitis | 1.23e-03 | 11 | 142 | 2 | EFO_0006505 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 1.34e-03 | 45 | 142 | 3 | EFO_0022236 | |
| Disease | Adenoid Cystic Carcinoma | 1.41e-03 | 100 | 142 | 4 | C0010606 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.42e-03 | 46 | 142 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | Mental Depression | 1.48e-03 | 254 | 142 | 6 | C0011570 | |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 1.52e-03 | 47 | 142 | 3 | EFO_0003892, EFO_0004713, EFO_0005671 | |
| Disease | neuroticism measurement | SETD1A SP4 ARPP21 PPFIA2 PCLO FNBP4 POM121L2 KLHL29 PTPRG KMT2A PRKD1 CDH7 | 1.52e-03 | 909 | 142 | 12 | EFO_0007660 |
| Disease | very low density lipoprotein cholesterol measurement | 1.67e-03 | 260 | 142 | 6 | EFO_0008317 | |
| Disease | cognitive function measurement, self reported educational attainment | 1.71e-03 | 355 | 142 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.71e-03 | 49 | 142 | 3 | EFO_0022256 | |
| Disease | free cholesterol in large LDL measurement | 1.92e-03 | 51 | 142 | 3 | EFO_0022176 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 1.92e-03 | 51 | 142 | 3 | EFO_0022242 | |
| Disease | Epilepsy | 1.93e-03 | 109 | 142 | 4 | C0014544 | |
| Disease | wellbeing measurement | BAZ2B PCLO FNBP4 MUC19 POM121L2 KLHL29 BPTF PTPRG KMT2A PRKD1 | 1.96e-03 | 692 | 142 | 10 | EFO_0007869 |
| Disease | bipolar disorder | 1.97e-03 | 577 | 142 | 9 | MONDO_0004985 | |
| Disease | total brain volume change measurement | 2.01e-03 | 14 | 142 | 2 | EFO_0021504 | |
| Disease | phospholipids in IDL measurement | 2.03e-03 | 52 | 142 | 3 | EFO_0022164 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 2.14e-03 | 53 | 142 | 3 | EFO_0022340 | |
| Disease | Hypertriglyceridemia | 2.32e-03 | 15 | 142 | 2 | C0020557 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 2.64e-03 | 16 | 142 | 2 | EFO_0020346 | |
| Disease | migraine disorder, fasting blood insulin measurement | 2.64e-03 | 16 | 142 | 2 | EFO_0004466, MONDO_0005277 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 2.77e-03 | 58 | 142 | 3 | EFO_0022338 | |
| Disease | cholesterol in IDL measurement | 2.77e-03 | 58 | 142 | 3 | EFO_0021899 | |
| Disease | parental longevity | 2.78e-03 | 494 | 142 | 8 | EFO_0007796 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 2.83e-03 | 121 | 142 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | Malignant neoplasm of skin | 2.91e-03 | 59 | 142 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 2.91e-03 | 59 | 142 | 3 | C0037286 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.98e-03 | 17 | 142 | 2 | EFO_0022232 | |
| Disease | total lipids in IDL | 3.06e-03 | 60 | 142 | 3 | EFO_0022161 | |
| Disease | urate measurement, bone density | 3.15e-03 | 619 | 142 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | triglycerides in small VLDL measurement | 3.20e-03 | 61 | 142 | 3 | EFO_0022145 | |
| Disease | free cholesterol in IDL measurement | 3.20e-03 | 61 | 142 | 3 | EFO_0022181 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 3.27e-03 | 206 | 142 | 5 | EFO_0004612, EFO_0020947 | |
| Disease | kidney volume | 3.35e-03 | 18 | 142 | 2 | EFO_0600044 | |
| Disease | Nuclear non-senile cataract | 3.35e-03 | 18 | 142 | 2 | C1112705 | |
| Disease | Nuclear cataract | 3.35e-03 | 18 | 142 | 2 | C0392557 | |
| Disease | phospholipids in large VLDL measurement | 3.35e-03 | 62 | 142 | 3 | EFO_0022169 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 3.35e-03 | 62 | 142 | 3 | EFO_0022339 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 3.51e-03 | 63 | 142 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 3.51e-03 | 63 | 142 | 3 | EFO_0022239 | |
| Disease | asthma | 3.52e-03 | 751 | 142 | 10 | MONDO_0004979 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 3.73e-03 | 19 | 142 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | emphysema pattern measurement | 3.73e-03 | 19 | 142 | 2 | EFO_0005850 | |
| Disease | triglycerides in small LDL measurement | 3.83e-03 | 65 | 142 | 3 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 3.83e-03 | 65 | 142 | 3 | EFO_0021902 | |
| Disease | susceptibility to cold sores measurement | 3.83e-03 | 65 | 142 | 3 | EFO_0008402 | |
| Disease | total lipids in small VLDL | 4.17e-03 | 67 | 142 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 4.17e-03 | 67 | 142 | 3 | EFO_0022175 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 4.17e-03 | 67 | 142 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | Microcephaly | 4.17e-03 | 67 | 142 | 3 | C0025958 | |
| Disease | Anophthalmia-microphthalmia syndrome | 4.55e-03 | 21 | 142 | 2 | cv:C5680330 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 4.55e-03 | 21 | 142 | 2 | EFO_0022246 | |
| Disease | Nephritis, Tubulointerstitial | 4.55e-03 | 21 | 142 | 2 | C0041349 | |
| Disease | Bladder Neoplasm | 4.76e-03 | 140 | 142 | 4 | C0005695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGSQATVASVVTSTL | 501 | P23470 | |
| SSREGTLSSVGLSSV | 1171 | P21860 | |
| ITSLTGTTNSITRDS | 96 | Q96KC9 | |
| ATAAAITATAATITT | 891 | Q4VCS5 | |
| ALSTGIAGISTSVTT | 406 | Q9N2J8 | |
| DGLSFISSSVIITTT | 301 | Q9H6X2 | |
| SVTSTTLIEILSDTG | 2326 | P13611 | |
| LTVTGSLADTRATSV | 2851 | Q68DQ2 | |
| LGASTTRISETSFST | 966 | Q8IZF6 | |
| TVSSDTSTRVGLFST | 1576 | Q8IZF6 | |
| TSTRVGLFSTLLSSV | 1581 | Q8IZF6 | |
| VVSTTALSATTASNA | 1081 | O60242 | |
| LAAGESSSLSASTSV | 311 | Q8IUR6 | |
| VIGINTSVLSTTASS | 181 | Q9UIF8 | |
| TLTVSVSLSASVSLG | 821 | Q14833 | |
| GSTTTSTTLRTTTLS | 436 | Q9HAR2 | |
| LTDTTTNILSGTTST | 3746 | Q8TCU4 | |
| GSTLSVISATSSAGR | 271 | O43299 | |
| VQLTFSAGESTTTVS | 1426 | Q9HCU4 | |
| TVTDSLTTTGGTLVT | 1786 | Q12830 | |
| LTTTGGTLVTSMTVS | 1791 | Q12830 | |
| FVSSSSLIATAGLST | 2846 | Q9Y485 | |
| GITVLTRGDSTSSTR | 386 | Q9UBL0 | |
| SITNSTLTSTGSSEA | 281 | Q3KR37 | |
| TVLTATATTTGATGS | 2021 | Q9HC84 | |
| TATVLTTTTTTVATG | 2101 | Q9HC84 | |
| STVTSHTLAATTGTT | 2231 | Q9HC84 | |
| LTELTTTATTTESTG | 2436 | Q9HC84 | |
| TSTVLTTTATTTGAT | 2576 | Q9HC84 | |
| STVLTTKATTTRATS | 3106 | Q9HC84 | |
| VLTTTATTTRATGSV | 3836 | Q9HC84 | |
| SLITTATTITATGST | 3946 | Q9HC84 | |
| LTELTTTATTTASTG | 4421 | Q9HC84 | |
| TSTVLTATATTTGAT | 4561 | Q9HC84 | |
| STLGTTRILTELTTT | 4811 | Q9HC84 | |
| ELTTTATTTAATGST | 4821 | Q9HC84 | |
| LIAATISSQISGSVT | 61 | Q13613 | |
| LTITSSLSSDGVLTV | 131 | P02511 | |
| VLTSTTGRTSLADSS | 6 | Q9H8V3 | |
| VLVTALVQSSSTSSS | 126 | Q8N130 | |
| SLLSGTAITVSDTVA | 161 | Q8N7Z5 | |
| AGTVTLRAGSTATSA | 1426 | O75147 | |
| TSSSVSEVVGSSTLS | 481 | Q02930 | |
| TTLGTVTGTVSTSLA | 881 | P51610 | |
| GDSVNITSSSAITTT | 1461 | P51610 | |
| ETAGSVLTLSTSAET | 801 | Q8WXI7 | |
| TSRSDVSGLTSESTA | 2151 | Q8WXI7 | |
| LSAAVVTGSSATSEA | 2546 | Q8WXI7 | |
| VTGSSATSEASLLTT | 2551 | Q8WXI7 | |
| TLQSTALGSGSTSIS | 3246 | Q8WXI7 | |
| AVVITSTSGDSIVST | 6331 | Q8WXI7 | |
| TELTSSSRTSIQGTE | 6401 | Q8WXI7 | |
| LTTGATETSRTEVAS | 6681 | Q8WXI7 | |
| SIGATTEISRTEVTS | 7271 | Q8WXI7 | |
| TEVTSSSRTSISGSA | 7281 | Q8WXI7 | |
| TEVTSSSRTSISGFA | 8156 | Q8WXI7 | |
| TTTTALKTTSRATLT | 10481 | Q8WXI7 | |
| ETTSSLATSLGAETS | 10536 | Q8WXI7 | |
| VVTSLVTSSSGVNST | 11041 | Q8WXI7 | |
| GLVTSLVTSSGSETS | 11206 | Q8WXI7 | |
| TSLVISSGTDSTTTF | 11461 | Q8WXI7 | |
| TQTTSSLFTLLVTGT | 11816 | Q8WXI7 | |
| GLLATSSSAETSTST | 11876 | Q8WXI7 | |
| VTDTSSASTGQATSL | 1251 | Q99102 | |
| STGQATSLLVTDTSS | 1466 | Q99102 | |
| TSLLVTDTSSVSTGD | 1471 | Q99102 | |
| TSLLVTDASSVSTGD | 1871 | Q99102 | |
| LLVTDASSVSTGDTT | 2481 | Q99102 | |
| TTSLAASAASTETLT | 321 | O43586 | |
| NVSLTGVSTIRTSSA | 206 | Q15139 | |
| GVSTIRTSSAELSTS | 211 | Q15139 | |
| ISSGSSASSVTVTRS | 611 | P02545 | |
| QVSSVRIVSASGTVS | 176 | Q8N9B5 | |
| TTTLFATSTIGVTTG | 2021 | Q2M2H8 | |
| TTVLIATTSSLTGTT | 2116 | Q2M2H8 | |
| VSNLTTASVTITATG | 2436 | Q2M2H8 | |
| TASVTITATGLDSQT | 2441 | Q2M2H8 | |
| ASTASTSLVVVTAAA | 1691 | Q8IWI9 | |
| VTTAASSLETSRGTS | 151 | P16150 | |
| STVSSGISIATNSES | 96 | Q5SSG8 | |
| ASTTDSGTTIASTRT | 96 | E2RYF6 | |
| STAGSETIVASTTVS | 121 | E2RYF6 | |
| IRASTVGSETTTVST | 586 | E2RYF6 | |
| TTASNTGLETTTVFT | 736 | E2RYF6 | |
| TATSLTGSETTTVSI | 1506 | E2RYF6 | |
| TTVSITASGATAAST | 1516 | E2RYF6 | |
| TVVGAAATTTTVTTK | 151 | Q86Z02 | |
| TLASSAGVLSTVQSA | 871 | O95714 | |
| TLSTIATSTDAASVV | 96 | Q16836 | |
| LSSSVSALDTITTVA | 571 | P52732 | |
| VISSLSNTILASTSS | 1416 | Q15652 | |
| SSVISTAEGTTRRTS | 1806 | Q3V6T2 | |
| LTSSVLSGASLTDST | 2106 | Q9Y6V0 | |
| GTTISVTASVTIALV | 341 | P55058 | |
| FSIDLVTGVVSSSST | 1291 | Q9NYQ8 | |
| TGITLDTTLSATETT | 491 | Q99542 | |
| SATDLGLTVSSLSTT | 76 | A6NGY5 | |
| AVSTTTATTILSTGA | 1646 | Q7Z5P9 | |
| TATTILSTGAAITLV | 1651 | Q7Z5P9 | |
| SVAVTRTSEQSSGVT | 2086 | Q7Z5P9 | |
| GLSAIVTETTGSSAR | 4096 | Q7Z5P9 | |
| LSAIVTETTGSSARS | 4406 | Q7Z5P9 | |
| SAVVTETTRLSSGVT | 4976 | Q7Z5P9 | |
| SAVVTETTRLSAGVT | 5366 | Q7Z5P9 | |
| TTGLSVEATVTTGLS | 5941 | Q7Z5P9 | |
| TTSVGRATGATTSIA | 6436 | Q7Z5P9 | |
| TTRGRITTATTGAFS | 6616 | Q7Z5P9 | |
| TTGVTTTTKTTTSLG | 6981 | Q7Z5P9 | |
| SIQSTETSSLVGTTS | 2531 | Q02505 | |
| GSTSTNAILTSFSTI | 2666 | Q02505 | |
| SGGSVTLSESTAIIS | 116 | Q96G04 | |
| LSGIVSISASSTTGV | 11 | P15421 | |
| TTSSEGTVSSNIRAL | 376 | Q8TC05 | |
| ITVTAVSASGLASAS | 391 | Q6UWB1 | |
| LSTTVTTLSSAVGTL | 396 | P09086 | |
| GIVASAAVVTTASST | 416 | Q7LBC6 | |
| GSTILVSNASLTTSV | 461 | Q9H1U4 | |
| SGTAASSTSLVALSA | 1551 | P35658 | |
| SVSSLVQTGISTDTI | 351 | P50748 | |
| TRTTITTTTTSSSGL | 6 | Q96S97 | |
| SSLSAETGSLSTESI | 401 | Q6ZVL6 | |
| QSTSLIGTLTRTSDS | 641 | Q6ZMI0 | |
| SSLTLGSGSSTTRLT | 2526 | Q7Z6Z7 | |
| SSGGTARFIISTSIT | 191 | Q8IZ21 | |
| ASGTAVTTTSAAVVS | 396 | P52756 | |
| SDISVSTVVLSFSSG | 186 | Q8WZ92 | |
| SGSTSGNTTTLTISR | 81 | A0A075B6J6 | |
| TLTRAGTLSTTGHST | 4221 | Q9P2D7 | |
| TVTESVTGISRNVST | 326 | Q6YHK3 | |
| VATATTVLSVGQSLS | 1621 | Q9ULT8 | |
| GTATSLDTAASLTST | 96 | Q96CN9 | |
| TTGISSTISFHSRTL | 1401 | Q6WRI0 | |
| TLSRSSSSVGGLSVS | 581 | Q92608 | |
| ITISITATAASIGAA | 406 | O00341 | |
| VTVSLTATLASVGAA | 426 | P43004 | |
| LTSVGVSVFTLTALS | 121 | P30550 | |
| VRSGSGISVISSTSV | 311 | Q15811 | |
| VGKDTSTTTIRVTST | 116 | Q49AR2 | |
| LSEIVSISASSTTGV | 11 | P02724 | |
| GTVTTETSSVVLTAA | 491 | Q5TEA3 | |
| ITTISITATAASVGA | 451 | P48664 | |
| SILSSASATVATVGQ | 91 | Q9NRY5 | |
| TRSVLGSSTVSKSSV | 176 | Q5VTH9 | |
| SLGAITTGTSTIVRT | 791 | Q9P2N6 | |
| VSGLASSSSVLNVVS | 3331 | Q03164 | |
| LSGTTTLTVTLTDVN | 256 | P55286 | |
| GLSGTTSVTVTLTDV | 241 | Q9ULB5 | |
| ITLGASTVSSVSSAR | 2821 | Q9NYQ7 | |
| SATGEESSTSLTIRV | 306 | Q9UQ72 | |
| ATESLTLLSTSAGTA | 486 | Q9Y467 | |
| LAEAVGVTTSTTTNT | 691 | Q9H329 | |
| GNVSDLSTTSTSLAT | 141 | P28906 | |
| IGQIITISITATSAS | 391 | P43005 | |
| GTSITASVTASSLAS | 701 | O75334 | |
| TNTGIATTITTGLTL | 81 | Q9BVL2 | |
| ITSTSASGLTLSSAL | 126 | Q9BVL2 | |
| VSTTLVASSEASTLS | 636 | Q685J3 | |
| TTLVASSAISILSTT | 1346 | Q685J3 | |
| VSTTLVVSSEGNTLS | 2051 | Q685J3 | |
| VSTTRVTSSEGSTLS | 3701 | Q685J3 | |
| DAVATSGVSTLSSTV | 1216 | Q99683 | |
| DLGSTEITATATTSL | 41 | Q92570 | |
| TSQATTALTAVVLSS | 686 | O00268 | |
| SLTSSDTLVSSADTG | 331 | Q02446 | |
| TVLRTLTSGSATFAL | 741 | Q969S9 | |
| LVSGSNSIISFSSVI | 196 | Q96KN7 | |
| LKSRSIVTSSGTTAS | 106 | Q7L2K0 | |
| ISTAVVQRSATIGSS | 796 | Q8N3X1 | |
| SLSSSSTATGTTVIE | 651 | Q5HYW2 | |
| RSLSNSSTATGTTVI | 961 | Q6T4R5 | |
| VVTTEIVGTTSLSSA | 396 | Q6ZSM3 | |
| VVSSSSVSNTTVAGT | 1196 | Q5UIP0 | |
| TASIATTLSSTSLSI | 521 | O60331 | |
| TERADTGTSILSVTS | 311 | O95343 | |
| SLTSLAQGTGTTSAI | 176 | Q96M27 | |
| SASSISVTSQVSSTG | 826 | Q15714 | |
| VTSGVAISTSVATAN | 1516 | Q9UHV7 | |
| LASVASSETSSLSLV | 2566 | Q6ZRS2 | |
| SGTTISSASLVSSQA | 301 | P08047 | |
| IISTILSISSTSGRS | 221 | Q8NH09 | |
| SIVVLSGTTAAQVTT | 406 | P40967 | |
| GHATISTAITASSST | 286 | O00444 | |
| TTASTAIAATTAATA | 321 | O15047 | |
| VTAAASSISSLSTIQ | 556 | Q96KW2 | |
| STDLTQTSSSGTVTL | 376 | P11831 | |
| STISGTRSTTVTFTV | 1666 | Q9UPX8 | |
| TTTTIGISATSATFT | 1511 | Q8IWZ3 | |
| ASTVSTKSVSTTGSL | 581 | Q7Z460 | |
| RVLTTTALSTVSSGV | 466 | O75122 | |
| TASGSSVVTASVQST | 1211 | Q6ZU65 | |
| SVVTASVQSTAGASL | 1216 | Q6ZU65 | |
| AGSVSITSLSSRTTE | 321 | Q6ZSR9 | |
| ISTIAGDSSRTSLVS | 116 | Q14119 | |
| TSLVSTIAGILSTVT | 126 | Q14119 | |
| TIAGILSTVTTSSSG | 131 | Q14119 | |
| TVTASTRSSVATTSG | 771 | Q14157 | |
| ATTGTQTLLSSGTRL | 696 | Q8IX01 | |
| VTSITGLSISAISTN | 181 | P55017 | |
| SSGTTQLRATATTLI | 216 | Q5VY80 | |
| ISTGVETTANSSTSL | 1366 | Q86X10 | |
| SGILTIDVASVSSTL | 626 | P98168 | |
| GSTTVGATLTSVSTT | 1481 | Q9H4A3 | |
| SSGTTQLRATATTLI | 216 | Q9BZM5 | |
| TLGSATTELLSGSTR | 606 | Q9H2Y7 | |
| ITSLTVDSVISSQGT | 261 | O95405 | |
| IGASSSSSTEALISA | 146 | Q86UZ6 | |
| LVTVTTSVGTGTRSL | 1066 | P49815 | |
| GSSEAITSLVASSAS | 76 | Q96CT2 | |
| ISARSTTSGLVEEST | 816 | Q9UKN1 | |
| ASSTTLGRSEESTTV | 3181 | Q9UKN1 | |
| ASSTTLGRSEESTTV | 4706 | Q9UKN1 | |
| TSTAAIGLSFTTSTT | 11 | Q9H1M0 | |
| LLSSTSTTTKITTGS | 586 | O14974 | |
| AAASTTTLTTTTAGT | 641 | O14974 |